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1 
Summary 
The kidney is one of the homeostatic regulators in the human body to maintain electrolyte and 
acid-base balance. An imbalance in acid-base regulation can lead to serious 
pathophysiological conditions. Possible reasons for a disturbed pH homeostasis are defects in 
genes encoding the transport proteins of the kidney. Mutations in the gene encoding the anion 
exchanger 1 (SLC4A1, AE1) is one of the genes that has been shown to cause distal renal 
tubular acidosis. 
During this study I have generated the first knock-in (KI) mouse models for autosomal 
dominant distal renal tubular acidosis (dRTA). These two independent knock-in (KI) mouse 
models, R607H and L919X, correspond to the human mutations R589H and R901X, 
respectively. No morphological and anatomical differences were observed in KI mice 
compared to WT littermates. In contrast, the established KI mouse models exhibit a renal acid 
secretion defect in steady state conditions which was also observed during a classical acid 
loading test. These observations were made on consecutive days while mice were housed in 
metabolic cages over a period of one week to measure urine pH and electrolytes. The blood 
gas analysis showed no significant differences in both KI mice compared to WT littermates. 
Human Patients with these mutations also show dRTA with lower blood pH and bicarbonate 
levels. 
A significant reduction of Ae1 expression levels was observed in cortical collecting ducts 
(CCD) of KI mouse kidneys by immunohistochemical analysis. The reduction in the protein 
expression is possibly due to the dominant negative effect of the mutations. The decrease in 
protein expression levels in KI kidney was validated by western blotting. Quantification of the 
transcript levels in the KI kidney tissues did not support a decrease in mRNA levels due to 
nonsense medicated mRNA decay. Thus, post-transcriptional effects are responsible for the 
decrease in Ae1 protein levels and account for dRTA. 
In summary, both KI mouse models provide valuable tools to further elucidate the 
pathomechanisms of AE1-related dRTA. 
 
 
 
 
2 
Zusammenfassung 
Die Niere ist ein wichtiger Regulator der Homöostase des Elektrolyt-und Säure-Base-
Haushalts. Störungen dieser Homöostase sind mit schwerwiegenden klinischen Folgen für die 
betroffenen Patienten verbunden. Eine der Ursachen einer gestörten pH-Regulation sind 
Defekte in verschiedenen Ionentransportern, die eine wichtige Rolle in der Regulation des 
Säure-Base-Haushalts spielen. Ein prominentes Beispiel für einen solchen Defekt sind 
Mutationen im SLC4A1-Gen, das für den Anionenaustauscher AE1 kodiert. Veränderungen 
im SLC4A1-Gen führen zum klinischen Bild der distalen renal-tubulären Azidose (dRTA).  
Im Rahmen meiner Dissertation habe ich die ersten Knockin-Mauslinien (KI) für das Slc4a1-
Gen zum Studium des Pathomechanismus der autosomal-dominanten dRTA hergestellt. Es 
wurden durch homologe Rekombination zwei unabhängige Mauslinien generiert, bei denen 
die Missense-Mutation R607H in das Slc4a1-Gen eingefügt wurde (diese entspricht der 
humanen Mutation R589H), sowie im zweiten Fall die Nonsense-Mutation L919X (diese 
entspricht der humanen Mutation R901X bei Patienten mit dRTA). Die jeweiligen 
heterozygoten KI-Mäuse wiesen keine offensichtlichen morphologischen Unterschiede im 
Vergleich zu ihren Wildtyp-Geschwistertieren auf. Daraufhin erfolgte eine Analyse des 
Säure-Base- sowie Elektrolythaushalts der Mäuse im Rahmen einer Versuchsreihe im 
metabolischen Käfig. Interessanterweise zeigte sich bei heterozygoten KI-Tieren beider 
Linien ein massiver Säuresekretionsdefekt, der sowohl unter Ruhebedingungen als auch nach 
Säurebelastung der Tiere nachweisbar war. Die Blutgasanalyse zeigte demgegenüber keine 
signifikanten Unterschiede zwischen KI- und Vergleichstieren. Diese Ergebnisse decken sich 
mit den laborchemischen Befunden von Patienten mit dRTA.   
Auf zellulärer Ebene konnte in beiden Linien eine signifikante Reduktion des 
Expressionsniveaus von Ae1 im kortikalen Sammelrohr heterozygoter KI-Tiere durch 
immunhistochemische Analysen nachgewiesen werden. Die Abnahme der Expression konnte 
durch Western-Blot Analysen bestätigt werden. Im Gegensatz dazu ergab die Quantifizierung 
der Ae1-Transkriptmenge in der Niere keine Abnahme der mRNA-Menge von Slc4a1. Somit 
scheinen posttranskriptionale Effekte für die Abnahme der Ae1-Proteinmenge und somit der 
dRTA verantwortlich zu sein. 
Zusammenfassend ist es im Rahmen der Dissertation gelungen, zwei Tiermodelle herzustellen 
und zu charakterisieren, die zum Verständnis des Pathomechanismus der AE1-assoziierten 
distal renal-tubulären Azidose beitragen.  
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1. Introduction 
1.1. Body homeostasis and acid-base balance 
The term homeostasis, originated from the Greek: ὅμοιος, hómoios, "similar" and στάσις, 
stásis, "standing still", is an important prerequisite for our body to maintain a constant internal 
milieu. Systemic acid-base homeostasis is maintained via complex interactions among 
metabolism, regulated exhalation of CO2 by the lungs and acid or base excretion/reclamation 
by the kidneys (Wagner, Kovacikova et al. 2006).  
Optimal activity of the physiological processes requires the control of intracellular and 
extracellular pH. pH is defined as the negative decadic logarithm of the proton (H
+
)
 
concentration:  
            
   
 
The pH of blood and extracellular fluids must be kept within a narrow physiological range 
around pH 7.4. Systemic pH homeostasis is achieved through integrated functions of 
intracellular and membrane bound acid-base transporters of the kidneys, lungs, and gut, 
coordinated and regulated by the endocrine and nervous system (Alper 2002).  
 
A controlled regulation of acid-base balance is necessary to maintain biochemical and 
metabolic functions of cells and organs. Therefore, a number of physiological buffering 
systems exist to control the pH of the body  (Giebisch and Windhager 2009). A buffer is a 
substance that helps to keep a constant pH by reversibly consuming or releasing protons 
(Boron, Boulpaep et al. 2009). Proteins, organic and inorganic phosphates, hemoglobin, 
creatinine, urate salts, and ammonia are relevent intra- and extracellular buffers. However, in 
biological systems the most important buffering system is the weak base HCO3
−
 in the CO2-
 
HCO3
−
 steady state (Tresguerres, Buck et al. 2010).  
 
CO2 + H2O  H2CO3  H
+
 + HCO3
−
 
 
Cellular enzymes and chemical reactions are sensitive to pH, and cells actively transport H
+
 
and HCO3
−
 across their cell membrane to maintain intracellular pH (Casey, Grinstein et al. 
2010). Extracellular pH and systemic acid-base balance are very important for normal organ 
and cellular function (Wagner, Devuyst et al. 2009). A disturbance in normal body acid-base 
status is associated with higher morbidity and mortality in patients with chronic kidney 
disease (Bailey 2005). Imbalances in the extracellular pH affect the stability and density of the 
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bone and can result or contribute to osteopenia and osteoporosis (Jehle, Zanetti et al. 2006; 
Arnett 2008).  
A standard western diet leads to the generation of approximately 1 mmol of nonvolatile 
mineral acid per kilogram of body weight (Cohen, Feldman et al. 1997). Maintenance of 
systemic acid-base balance requires renal excretion of an equivalent amount of acid. The 
kidney meets this requirement using two principal mechanisms: reabsorption of filtered 
HCO3
−
 by the proximal tubule and net acid excretion as titratable acids and NH4
+
 by the distal 
nephron (Kurschat and Alper 2008). 
 
1.2. Role of membrane proteins in acid-base balance 
Membrane proteins are approximately one third of all proteins encoded by eukaryotic 
genomes (Muller, Wu et al. 2008). These proteins perform their functions as enzymes, 
receptors, channels, structural proteins and transporters and are involved in essential 
biological processes such as electron transport, transmembrane signalling, nerve conduction 
and nutrient uptake. The phospholipid bilayer, the basic structural unit of the cell membrane, 
is mostly impermeable to water soluble molecules, ions and water. Transport across 
membranes is necessary to maintain ion concentration gradients which are essential 
prerequisites for the function of most mammalian cells, e.g. epithelial cells in the kidney. The 
transport of H
+
 and HCO3
− 
across the cell membrane regulates the intra and extracellular pH 
homeostasis. The transport across cellular membranes can be categorised into passive and 
active transport processes.  
 
 
Figure 1.1 Overview of membrane transport proteins. (1) ATP-powered pumps utilize the energy released by 
ATP to move ions or small molecules against the concentration gradient. (2) Channels allow the movement of 
specific ions or water along with their concentration gradient. Transporters further divided into three groups. 
(3A) Uniporters transport a single type of molecule down its concentration gradient. The co-transporters can be 
(3B) symporters, also known as cotransporters or (3C) antiporters, commonly called as exchangers, catalyse the 
movement of one molecule against its concentration gradient (black circles), driven by movement of one or more 
ions down an electrochemical gradient (red circles) (Lodish 2003). 
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1.2.1. Passive and active transport across membranes 
Gases and small uncharged polar molecules can readily move across membranes by passive 
transport. Their transfer rate is depending upon the concentration gradient across membranes. 
When integral membrane proteins are involved in passive transport this is known as facilitated 
transport (Lodish 2003). Transport proteins can be classified in four groups, namely pores, 
channels, carriers (also referred to as transporters and exchangers) and pumps. The expression 
of some transport proteins can be specific for tissues, cell types, and sometimes membrane 
domains. Others are expressed in most, if not all cell membranes (Reuss 2008). 
Ion channels and the porins are example of proteins, which have a polar pore through which 
ions and other hydrophilic compounds can pass. Transporters bind molecules to be 
transported and help them to pass through the membrane by a conformational change. 
Active transport works (always) opposite to the concentration gradient and therefore requires 
an input of energy, which is usually supplied by the hydrolysis of ATP. Transport systems in 
the membranes are essential for the cells to regulate volume, nutrient uptake, waste removal 
internal pH value, and to establish ion gradients, which are required for oxidative 
phosphorylation and stimulation of muscle and nerve cells (Koolman and Röhm 2005). 
 
1.3. Solute carriers and anion exchanger proteins 
To maintain a physiological cellular environment, molecules must be delivered into and 
removed from cells and organelles. This important role is performed by transport proteins that 
reside in plasma and intracellular membranes. The solute carrier (SLC) families includes more 
than 300 genes that encode passive transporters, ion-coupled transporters, and exchangers 
(Landowski, Suzuki et al. 2008). 
Anion exchangers are key regulators of intracellular homeostasis by maintaining 
physiological balance from cells to whole organs by transporting different anions such as Cl
−
, 
HCO3
−
, SO4
2−
 and oxalate across cell membranes. Their pivotal role in the regulation of 
intracellular pH, cell volume, CO2 metabolism, cell shape, contractility and contribution to 
cell growth, as well as ion gradients has been previously known. Two important anion 
exchanger families support to maintain the physiological functions of eukaryotic systems, the 
classical anion exchanger (AE) gene family, known as solute carrier 4 (SLC4) and a 
multifunctional anion exchanger family solute carrier 26 (SLC26). Differences in the tissue 
distribution and regulation of the specific anion exchanger proteins allow the precise 
regulation of bicarbonate transport throughout the human body (Pushkin and Kurtz 2006; 
Bonar and Casey 2008). 
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1.3.1. Solute carrier family 4 (SLC4) and anion exchanger 1 (AE1) 
The SLC4 gene family includes 10 members. This solute carrier family can be subdivided into 
two major subfamilies based on the function: anion exchangers (AEs) and sodium coupled 
bicarbonate co-transporters (NBCs) (Romero 2005; Landowski, Suzuki et al. 2008). 
 
 
Figure 1.2 Phylogenetic dendrogram of human bicarbonate transporters. The length of the line represents 
the relative evolutionary distance. Bicarbonate transporters clearly cluster into three families, each of which is 
coloured and labelled. SLC4A11, which may or may not be a bicarbonate transporter, is placed midway between 
the electrogenic and electroneutral Cl
−
/HCO3
−
 exchangers (Cordat and Casey 2009). 
 
The first three human AEs (AE1-3) have been characterized as electroneutral exchangers, 
which carry one monovalent anion in exchange for a second monovalent anion. These anion 
exchangers transport HCO3
−
 and Cl
−
 and this electroneutral transport process is inhibited by 
stilbene disulfonate derivatives such as DIDS (Landowski, Suzuki et al. 2008). All SLC4 
polypeptides are structurally very similar, consist of an N-terminal hydrophilic, cytoplasmic 
domain followed by a hydrophobic, polytopic transmembrane domain, and completed by a C-
terminal cyto lasmic domain. Many SLC4 genes ex ress 5′-variant transcripts from different 
promoters to generate one or more isoforms with distinct N-terminal amino acid sequences 
(Alper 2006). The AE1 gene encodes the longer erythroid AE1 (eAE1, band 3) and the shorter 
kidney AE1 (kAE1) which initiates at Met66 in human and at Met80 in mice (Kopito, 
Andersson et al. 1987; Kudrycki and Shull 1993) (see figure 1.3). The mouse AE2 gene 
encodes five N-terminal variant polypeptides (the human gene encodes only four), while the 
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AE3 gene encodes two variant N-terminal and two variant C-terminal polypeptide sequences 
(Alper 2009). 
 
1.4. Anion exchanger 1 (AE1, SLC4A1) 
AE1, the Cl
−
/HCO3
−
 exchanger of erythrocytes, was one of the first transporters to be 
physiologically identified. Among the members of the SLC4 family, AE1 was also the first to 
be cloned (Kopito and Lodish 1985). AE1 is also known as the Band 3 protein for its position 
in the SDS-polyacrylamide gel electrophoresis of the erythrocyte membrane proteins. AE1 
(SLC4A1) represents 25% of the total membrane proteins of red blood cells  and is the most 
abundant membrane glycoprotein in erythrocytes (Kopito and Lodish 1985). AE1 is an 
important structural component of red blood cell membranes and also involved in the 
movement of CO2 from organs to the lungs.  
 
Human Chromosome 17 (Mouse Chromosome 11) 
 
 
Figure 1.3 The human anion exchanger 1 (AE1) gene. The human AE1 gene is located on chromosome 17 
(Mouse chromosome 11), spans 20 kb and consists of 20 exons and 19 introns. Exons are indicated by vertical 
filled and unfilled bars while introns by lines between the bars. The same gene encodes both the erythroid 
(eAE1) and the kidney (kAE1) protein isoforms using different promoters and start codons, resulting in different 
lengths of the respective polypeptides. The eAE1 contains 911 (mouse 929) amino acids whereas kAE1 lacks 65 
(mouse 79) amino acids at the N-terminus (Yenchitsomanus 2003). 
 
In the kidney, a shorter N-terminal variant of AE1 (kAE1) is the major isoform. This variant 
is derived from an alternative promoter site that results in a unique transcript that lacks the 
Mouse 929 amino acids 
Mouse lack first 79 amino acids 
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first 65 amino acids (Human) of erythroid hAE1 (Brosius, Alper et al. 1989). AE1 (SLC4A1) 
is localized to the basolateral membrane of α-intercalated cells of the collecting duct (Alper, 
Kopito et al. 1988; van Adelsberg, Edwards et al. 1993; Huber, Asan et al. 1999; Alper, 
Darman et al. 2002) where it is essential for normal distal urinary acidification (Stehberger, 
Shmukler et al. 2007). AE1 is also expressed at lower levels in the heart with a cardiac 
specific isoform (Richards, Jaconi et al. 1999). 
Ae1 knock out (KO) mice exhibit dRTA characterized by spontaneous hyperchloremic 
metabolic acidosis with low net acid excretion and inappropriate, alkaline urine without 
bicarbonaturia. The basolateral Cl
–
/HCO3
–
 exchange activity in acid secretory intercalated 
cells of isolated superfused Ae1 KO medullary collecting duct was reduced, but alternative 
bicarbonate transport pathways were upregulated. Ae1 KO mice also manifest 
nephrocalcinosis associated with hypercalciuria, hyperphosphaturia, and hypocitraturia. A 
severe urinary concentration defect in Ae1 KO mice was accompanied by dysregulated 
expression and localization of the aquaporin-2 water channel (Stehberger, Shmukler et al. 
2007). 
 
 
Figure 1.4 Topological model of the human AE1 secondary structure. Highlighted sites of missense or in-
frame deletion mutations associated with dRTA (green); frameshift, nonsense, in-frame deletion, and missense 
mutations associated with hereditary spherocytosis (HS) and other erythroid phenotypes (orange); and sites of 
blood group polymorphisms (blue). Consecutive green residues at the C terminus represent the dRTA mutation 
R901X. Consecutive orange residues at Δ117–22 and Δ400–408 represent in-frame deletions. Red circles 
indicate the mutation selected to generate KI mice (Alper 2002; Zhu, Lee et al. 2003). 
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1.4.1. Topological organization of AE1  
The model of the AE1 monomer can be seen in figure 1.4. AE1 is present as a dimer or 
tetramer in the red blood cell membrane (Alper 2009). The N-terminal domain of human AE1 
is located in the cytoplasm, where cytoskeletal components, haemoglobin, or glycolytic 
enzymes can attach (Chu and Low 2006; Campanella, Chu et al. 2008; Chu, Breite et al. 
2008). The N-terminal domain provides the binding sites for the erythroid cytoskeletal 
proteins ankyrin-1 (Chang and Low 2003; Stefanovic, Markham et al. 2007), protein 4.2 
(Toye, Ghosh et al. 2005), the ERM protein 4.1R (Salomao, Zhang et al. 2008) and integrin-
linked kinase (Keskanokwong, Shandro et al. 2007). 
 
 
 
 
 
Figure 1.5 Structural and functional organization of human erythroid AE1 Adapted from (Wrong, Bruce et 
al. 2002) Schematic representation of exchange of bicarbonate (HCO3
−
) and chloride (Cl
−
) ions via AE1, which 
promotes the release of oxygen from haemoglobin by lowering the pH within the red blood cell. (Riken research 
Japan) 
 
Analysis of the AE1 amino acid sequence suggests a transmembrane domain model with 14 
α-helical transmembrane spans, including two re-entrant loops in the C-terminal portion of the 
transmembrane domain as predicted by cysteine scanning mutagenesis studies of AE1 (Zhu, 
Lee et al. 2003; Zhu and Casey 2004). The chemical modification of AE1 in intact red blood 
cells has suggested that in addition to glutamate residues histidine, arginine and lysine 
residues each contribute to anion transport and selectivity (Stewart, Kurschat et al. 2008).  
The binding site for the stilbene inhibitors is believed to be the lysine residues that react 
covalently (Salhany, Cordes et al. 2005). The central transmembrane domain of AE1 carries 
out the anion exchange function as well as carries the interaction sites for glycophorin A, 
which acts like a `β-subunit' for AE1 trafficking and optimal function in red blood cells 
(Young, Beckmann et al. 2000; Williamson and Toye 2008). The C-terminal tail of AE1 and 
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other SLC4 polypeptides contains one or more acidic motifs that may serve as a binding site 
for cytoplasmic carbonic anhydrase II (CAII) (Vince and Reithmeier 1998; Reithmeier 2001; 
Sterling, Reithmeier et al. 2001). 
 
1.5. The Kidney as an organ for acid-base balance 
1.5.1. Basic anatomy 
The Kidneys are paired retroperitoneal organs in the posterior part of the abdomen on each 
side of the vertebral column (Madsen, Nielsen et al. 2008). Two major regions can be seen in 
the longitudinal dissection of the kidney in figure 1.6, the cortex and the medulla. The 
medulla can be further divided into the outer and the inner medulla and the outer medulla sub-
divided into an inner and an outer stripe (figure 1.7). 
 
Figure 1.6 The bisected kidney depicting important anatomic structures. (Madsen KM, Nielsen S, Tisher 
CC: Anatomy of the Kidney. In: Brenner and Rector's the Kidney, 8th ed., WB Saunders, 2008) 
1.5.2. Physiology of acid secretion by the kidney 
The nephron is the basic functional unit of the kidney. The primary urine is filtered in the 
glomerulus, and then the filtrate passed the tubular system of the kidney. The post glomerular 
tubules of the nephron are lined by highly polarized cells; one surface is in contact with the 
urine and the other with interstitial fluid (Devonald 2004). Therefore, transport proteins reside 
very strictly either to the apical or the basolateral side of the plasma membrane. Moreover, a 
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highly specialized machinery is required to bring these transport proteins to their appropriate 
site of action (Devonald 2004). 
The kidneys control the acid-base homeostasis by the following two ways: (1) reabsorption of 
bicarbonate (HCO3
−
) filtered at the glomerulus and (2) the excretion of acid (H
+
) and 
ammonium (NH4
+) to accom lish  roduction of “new” bicarbonate to re lace that consumed 
by dietary or endogenous metabolic acids (Hamm and Nakhoul 2008).   
 
Figure 1.7 Basic anatomy of the kidney and nephron. The tip of the conical inner medulla (IM) known as 
papilla; PCT, proximal convoluted tubule; LDL, long descending thin limb of Henle; LAL, long-ascending thin 
limb of Henle (inner medulla only); MTAL, medullary thick limb of Henle (outer medulla only); DCT, distal 
convoluted tubule; CNT, connecting tubule; CCD, cortical collecting duct; OMCD, outer medullary collecting 
duct; IMCD, inner medullary collecting duct. (Thomas 2009) 
 
Reabsorption of the filtered HCO3
−
 in the  roximal tubule accounts for the ≈75% to 80% of 
the total HCO3
−
 in glomerulus filtrate. In proximal renal tubular acidosis non-absorbed HCO3
−
 
spills into the urine, ultimately lowering plasma HCO3
−
. However, normally almost all of the 
filtered HCO3
−
 is reabsorbed (Shayakul and Alper 2000; Hamm and Nakhoul 2008). The 
mechanism is based on the reabsorption of H
+
 and HCO3
−
 ions are generated in tubular cells 
with the help of CAII. The H
+
 ions are then secreted into the lumen via a Na
+
/H
+
 exchanger in 
the apical membrane and the HCO3
−
 ions transferred via a basolateral Na
+–HCO3
−
 co-
transporter (Unwin, Shirley et al. 2002). The H
+
-ATPase actively secrete H
+
, and these ions 
react with filtered HCO3
−
 to form H2CO3, which is rapidly converted to CO2 and H2O by 
another form of CA(IV) present in the luminal membrane of the proximal tubule. The CO2 
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and H2O then diffuse into the cell (Laing, Toye et al. 2005). Generation of “new”  CO3
− 
is 
the second im ortant role of kidney; “new”  CO3
−
 refers to HCO3
−
 that is produced by the 
kidneys, but that was not filtered at the glomerulus. Production of new HCO3
−
 is 
accomplished by excretion of titratable acid (TA) and excretion of NH4
+
. The titratable acid 
equals the amount of acid (H
+
) that is added to tubular fluid along the nephron, thus titrating 
urinary buffers. Titratable acid is a function of both urine pH and buffering capacity (Hamm 
and Simon 1987). 
HCO3
−
 that is not reabsorbed by the proximal tubule can be reabsorbed by the epithelial cells 
of the thick ascending limb. The major apical mechanism for HCO3
−
 entry into the cell is 
NHE3, with basolateral membrane Cl
−
/HCO3
−
 exchanger AE2/SLC4A2 probably mediating 
base efflux across the basolateral membrane into the interstitium (Watts and Good 2004). 
The distal nephron includes distal convoluted tubule, the connecting tubule, the cortical 
collecting duct, the outer medullary collecting duct, and the initial portion of the inner 
medullary collecting duct. The connecting segment and collecting ducts consists of two major 
cell types; principal cells account for approximately 60% of tubular epithelial cells and 
intercalated cells for the remaining 40%. Two main types of intercalated cells are present in 
the connecting segment and cortical collecting duct the ty e A or α-intercalated cells which 
secrete H
+
 and ty e B or β-intercalated cells which secrete HCO3
−
 (Batlle, Ghanekar et al. 
2001; Wagner and Geibel 2002). 
Acid secreting α-intercalated cells express the vacuolar H+-ATPase at the apical membrane 
and the Cl
−
/HCO3
−
 exchanger (AE1) at the basolateral membrane. Conversely, the HCO3
− 
secreting β-intercalated cells express the H+-ATPase at the basolateral membrane and the 
Cl
−
/HCO3
−
 exchanger (Pendrin) at the apical membrane. All intercalated cell types express 
the cytoplasmic carbonic anhydrases CA II (Kurschat and Alper 2008). 
The complex heteromeric H
+
-ATPase is encoded by 14 genes and comprise of two major 
domains, a transmembrane V0 segment and an intracellular catalytic V1 segment. The B1 and 
a4 subunit is encoded by the ATP6V1B1 and ATP6V0A4 genes respectively, are expressed at 
high levels in the collecting duct intercalated cells, as well as in narrow and clear cells of the 
epididymis, in the ciliary body of the eye, in the inner ear, and in the placenta (van Hille, 
Richener et al. 1994; Smith, Skaug et al. 2000; Stehberger, Schulz et al. 2003; Wagner, 
Finberg et al. 2004). 
The acid secreting α-intercalated cells transport HCO3
−
  across the basolateral membrane by 
the SLC4A1 electroneutral Cl
−
/HCO3
− exchanger, kidney AE1 (kAE1) and the β-intercalated 
cells secrete HCO3
–
 through an apical Cl
–
/HCO3
− 
exchanger (Pendrin)(see Figure 1.8) (Alper, 
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Natale et al. 1989; van Adelsberg, Edwards et al. 1993; Royaux, Wall et al. 2001). Expression 
of pendrin is reduced in rat kidney by acid loading and modestly increased in response to 
alkali loading (Wagner, Finberg et al. 2002; Frische, Kwon et al. 2003; Petrovic, Wang et al. 
2003). 
 
Figure 1.8 Schematic model of renal 
acidifying mechanisms: HCO3
−
 
reabsorption in proximal tubular cells 
and H
+
 secretion in α-intercalated cells 
of the collecting duct.  
Protons are secreted at the apical 
membrane by the NHE3 Na
+
/H
+
 
exchanger and by the vacuolar H
+
-
ATPase in the proximal tubule. 
Carbonic anhydrase (CA) IV catalyzes 
the formation of CO2 from H2CO3 and 
the CO2 can enter intracellularly by 
diffusion. H2CO3 is formed in the 
presence of cytosolic CA II, and HCO3
–
 
is transported out of the cell at the 
basolateral surface by Na
+
/HCO3
−
 co-
transporter NBCe1.  
In α-intercalated cells of the cortical 
collecting duct, protons are transported 
out of the cell into the lumen by the 
vacuolar H
+
-ATPase. HCO3
−
 generated 
inside the cells leaves via the anion 
exchanger 1 (kAE1) in exchange for 
Cl
−
 entry across the basolateral 
membrane. The β-intercalated cells 
secrete HCO3
–
 in exchange for Cl
− 
via 
their apical anion exchanger pendrin. In 
contrast to α-intercalated cells, they can 
express a basolateral vacuolar H
+
-
ATPase. (Kurschat and Alper 2008). 
 
 
The anion exchanger pendrin (PDS, SLC26A4) was initially identified as being mutated in 
patients suffering from Pendred syndrome (Everett, Glaser et al. 1997; Scott, Wang et al. 
1999). In the kidney,  endrin is s ecifically ex ressed on the luminal membrane of β-
intercalated cells (Royaux, Wall et al. 2001; Kim, Kwon et al. 2002). It mediates Cl
−
/HCO3
− 
exchange releasing bicarbonate into the urine and reabsorbing chloride. Pendrin is critical for 
bicarbonate secretion during metabolic alkalosis (Royaux, Wall et al. 2001).  
 
1.6. Familial renal tubular acidosis 
The importance of renal acid-base transport has been revealed by mutations found in several 
genes involved in this task in patients with inborn forms of renal tubular acidosis. Loss of 
function in AE1, ATP6V1B1 and ATP6V0A4 genes due to different mutations are possible 
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causes of hereditary renal tubular acidosis (RTA). The underlying mechanisms have been also 
studied in genetically altered mouse models and cell culture systems (Finberg, Wagner et al. 
2005; Wagner, Kovacikova et al. 2006). 
The term renal tubular acidosis (RTA) is applied to a group of transport defects in the 
reabsorption of bicarbonate (HCO3
−
), the excretion of protons (H
+
), or both. This condition 
was first described in the 1930’s (Lightwood 1935; Karet, Gainza et al. 1998; Rodriguez 
Soriano 2002). Distal RTA arises when the collecting duct fails to remove the excess acid 
load of a normal diet into the urine and it is often associated with mutations in the AE1 
protein (Quilty, Li et al. 2002; Karet 2008).  
 
In the distal type of RTA (dRTA), the secretion of hydrogen ions (H
+
) in the distal tubule of 
the nephron is impaired, whereas the proximal reabsorption of bicarbonate and other solutes is 
intact (Batlle, Ghanekar et al. 2001). The classic type of RTA (type I or dRTA) is 
characterized by a reduced net acid excretion and inability to lower urinary pH below 5.5 
before or after acid loading (Batlle and Kurtzman 1982; Caruana and Buckalew 1988). 
Hereditary dRTA comes in three variants: autosomal dominant and autosomal recessive with 
or without deafness (Fry and Karet 2007; Alper 2010). Genetic defects in AE1 and the a4 or 
B1 subunit isoforms of vH
+
-ATPase lead to defective acid secretion by intercalated cells in 
the distal tubule and collecting duct, which results in renal tubular acidosis (Karet, Finberg et 
al. 1999; Alper 2002).  
Primary dRTA results in metabolic acidosis of variable severity, usually with hypokalemia, 
hypercalciuria, and hypocitraturia. Rickets and osteomalacia can develop in both dominant 
and recessive forms, although dominant disease typically presents more mildly in adolescence 
or adulthood, and recessive in infancy/early childhood where growth retardation is common 
(Karet 2002). Chronic metabolic acidosis decreases renal excretion of citrate while increasing 
calcium excretion, which favors the formation of kidney stones and nephrocalcinosis (Batlle, 
Ghanekar et al. 2001). Hereditary autosomal dominant dRTA in general (but not always) 
presents at later age, sometimes not until adulthood, and with milder phenotype than the 
recessive form of dRTA (Karet 2002; Fry and Karet 2007). 
 
The diagnosis of classic dRTA is based on the finding of a high urine pH in the setting of a 
systemic metabolic acidosis. The systemic pH may be fully compensated (so called 
"incomplete" dRTA), in which case a failure of urinary acidification should be addressed 
pharmacologically by an oral ammonium loading test or the recently proposed combination of 
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furosemide/fludrocortisone as an alternative (Batlle and Kurtzman 1982; Unwin, Shirley et al. 
2002). Distal renal tubular acidosis can be treated with appropriate doses of oral alkali 
supplementation (5–15 mEq · kg–1 · day–1 of bicarbonate) to reverse the metabolic acidosis 
and normalize bone growth in children (Kurtzman 2000). 
 
1.7. Mutations associated with the human AE1 gene 
AE1 is the most abundant protein in erythrocytes and highly expressed in the acid-secreting α-
intercalated cells of the renal collecting duct. In erythrocyte, eAE1 stabilizes the underlying 
cytoskeleton and increases the CO2 carrying capacity of blood. In the kidney, intercalated cell 
absorbs HCO3
− 
via kAE1 upon apical H
+
 excretion into the urine. Therefore, mutations in 
AE1 gene are thus, not surprisingly, characterized by erythroid and renal phenotypes 
(Kurschat and Alper 2008; Stewart, Kurschat et al. 2008).  
 
1.7.1. Mutations in AE1 causing erythrocyte phenotypes 
Hereditary spherocytosis (HS) is a common congenital haemolytic anaemia which is 
associated with osmotically fragile red cells with varying degrees of abnormal spheroidal 
shape. This disease can result from defects in any of the red cell skeletal components which 
are involved in stabilizing the lipid bilayer (Hassoun and Palek 1996). Mutations in the 
erythroid isoform of AE1 (eAE1) causes hereditary spherocytic (HS) anemia. Many of these 
mutant alleles generate instable transcripts, therefore resulting erythrocytes express reduced 
total levels of the wild type eAE1 polypeptide, but often in the setting of dosage 
compensation by the wild type allele (Alper 2009). The autosomal dominant HS patients 
almost always have apparently normal renal acidification. Alterations in the conserved 
arginines in the membrane domain result in hereditary spherocytosis (Jarolim, Rubin et al. 
1995). The Southeast Asian Ovalocytosis (SAO) is caused by an autosomal dominant, 
heterozygous in-frame deletion of AE1 amino acids 400–408 (see figure 1.4). The deletion of 
these amino acids in AE1 alters the shape of erythrocytes (Southeast Asian ovalocytosis, 
SAO) but exhibits no clinical pathology. It is also suggested that the prevalence of SAO in 
areas prone to cerebral malaria epidemics provides a natural protection because of increased 
rigidity of the erythrocyte membrane (Tanner 1997; Allen, O'Donnell et al. 1999).  
 
1.7.2. Distal renal tubular acidosis (dRTA) due to AE1 mutations 
Distal renal tubular acidosis (dRTA) is characterized by impaired urinary acid excretion in the 
distal part of kidney tubules. In most cases hereditary dRTA caused by the defect in acid 
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secreting intercalated cells (α-IC) of the collecting ducts is due to mutations in AE1. Missense 
mutations in kidney AE1 (SLC4A1) are associated with autosomal dominant distal tubular 
acidosis, which is characterized by malfunctioning urinary acidification (Jarolim, Shayakul et 
al. 1998).  
Several mutations in the membrane spanning domain of AE1 at R589 in TM 6 (Bruce, Cope 
et al. 1997; Jarolim, Shayakul et al. 1998; Karet, Gainza et al. 1998), S613F in TM 7 (Bruce, 
Cope et al. 1997), DV850 (Bruce, Wrong et al. 2000), and an 11-amino acid deletion in the 
cytoplasmic C terminus (Karet, Gainza et al. 1998) can produce an autosomal dominant distal 
renal tubular acidosis (dRTA) that has no associated erythrocyte pathology. Most of these 
mutations (R589H, R589C, R589S, G609R, R901X) caused aberrant targeting of kAE1 in 
polarized kidney cells of the transporter (Devonald, Smith et al. 2003; Toye, Banting et al. 
2004), but few others (G701D and S773S) resulted in AE1 misfolding (Kittanakom, Cordat et 
al. 2004). The AE1 mutants associated with dominant dRTA expressed in Xenopus oocytes 
usually exhibit normal or modestly reduced Cl
−
 and HCO3
−
 transport function which cannot 
explain the renal phenotype. The defective urinary acidification is thought to arise from the 
trafficking defects of these mutant polypeptides in the polarized epithelial cells.  
 
 
Figure 1.9 The α-intercalated cell in the collecting tubule of the distal part of the nephron  
Type A-intercalated cells (α-IC) in the collecting tubule secrete H+ into the lumen via H+ -ATPase. The 
generation of H
+
 is catalysed by carbonic anhydrase II the resulting HCO3
-
 is transported across the basolateral 
membrane through the AE1 HCO3
−
/Cl
−
 exchanger. Mutations in AE1 and the B1 unit of H
+
-ATPase cause 
autosomal dominant and autosomal recessive distal renal tubular acidosis (Bonnardeaux and Bichet 2008). 
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Some of the dominant dRTA mutant proteins such as AE1 R589H (Jarolim, Shayakul et al. 
1998) and S613F are retained in the endoplasmic reticulum, and exert a dominant negative 
trafficking phenotype within heterodimers with the wild type AE1 polypeptide (Alper 2009). 
A second group carries only one truncating mutation, AE1 R901X causes the deletion of 11 
amino acids in the C-terminal in a dominant dRTA manner. It has been shown that this mutant 
accumulates either uniquely in the apical membrane or in both apical and basolateral 
membranes of polarized MDCK cells, possibly due to the loss of a sorting or retrieval signal 
related to residues 904–907 (Devonald, Smith et al. 2003; Toye, Banting et al. 2004; Cordat, 
Kittanakom et al. 2006). It is proposed that the presence of functional, mistargeted kAE1 in 
the apical membrane of the α-IC cells likely short-circuits acid secretion through a co-
dominant mechanism. However, substantial intracellular retention of this mutant has been 
observed (Cordat 2006) and more extensive, engineered truncation of the C-terminal tail 
further increased intracellular retention of the mutant protein (Dahl, Jiang et al. 2003; Cordat 
2006). Mistargeting of kAE1 to the apical membrane can be due to the mutation of sequence 
elements in both the N-terminal cytoplasmic domain and in the C-terminal cytoplasmic tail. 
Basolateral localization of human kAE1 possibly depends upon two phosphorylatable 
tyrosines, Y359 in the N-terminal cytoplasmic domain and Y904 in the C-terminal tail (Toye, 
Banting et al. 2004).  
 
The homozygous AE1 mutants causing recessive dRTA are geographically localized to 
Southeast Asia (Tanphaichitr, Sumboonnanonda et al. 1998; Bruce, Wrong et al. 2000). 
The AE1 G701D is a common example of a recessive dRTA mutation. In this case the mutant 
protein is retained inside the cell, but the trafficking to the cell surface can be rescued by 
coexpression of glycophorin A. This rescue by an erythroid protein which is not expressed in 
renal intercalated cells can explain the normal erythroid AE1 expression in these patients 
(Tanphaichitr, Sumboonnanonda et al. 1998). The recessive dRTA caused by compound 
heterozygous mutations of AE1 is sometimes accompanied by the south asian ovalocytosis or 
the hereditary spherocytosis. The functionally inactive SAO allele fails to complement a 
recessive loss-of-function in the α-intercalated cell (Bruce, Wrong et al. 2000). The knock out 
animal models of AE1 exhibit disease phenotypes, severe hemolytic anemia (Peters, 
Shivdasani et al. 1996) and a hypercoagulable state (Hassoun, Wang et al. 1998), 
accompanied by complete dRTA (Stehberger, Shmukler et al. 2007).  
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1.8. Aim of this study 
Renal tubular acidosis (RTA) is a failure of renal regulatory mechanisms to maintain systemic 
pH homeostasis. Hereditary distal renal tubular acidosis (dRTA) is associated with mutations 
in genes that result in a defect of H
+
 secretion by intercalated cells in the distal nephron. The 
anion exchanger 1 (AE1) is expressed in the basolateral membrane of α-intercelated cells of 
the kidney tubules and is thought to support urinary acid secretion by retrieving back HCO3
−
 
into the blood. Mutations in the human AE1 gene are supposed to result in mistargeting or 
loss of functional protein. 
 
The main focus of this study was to generate mouse models for dRTA to study the 
pathophysiology of the disease by introducing the respective mutation into the mouse Ae1 
gene. The underlying cellular mechanisms of dRTA are poorly understood. So, Ae1-knock in 
mice were generated to address 1. the underlying cellular pathology, 2. to study the potential 
compensatory mechanisms and 3. to access the long term effects of dRTA on the formation of 
kidney stones and other secondary effects associated with dRTA. 
These mouse models can also be used to study the effect of the impaired protein expression in 
homozygous condition that has so far not been detected in human patients. 
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2. Materials and methods 
2.1. Materials 
2.1.1. Chemicals 
The chemicals used during this work were of analytical grade and purchased from sigma, 
merck, or carl roth.  Enzymes were obtained from Roche, Invitrogen, New England Biolabs 
and Fermentas. Oligonucleotides were synthesized at MWG-Biotech. Radioactive nucleotides 
were obtained from Hartmann analytic. 
2.1.2. Microbial strains and laboratory animals 
The list of bacterial strains and experimental organisms were described in table 2.1. 
Table 2.1 Organisms and bacterial strains used in this study 
Bacterial Strain Escherichia coli TOP’ 10 Stratagene 
Bacterial Strain Escherichia coli XL1 blue Stratagene 
Laboratory Animals Mus musculus (C57BL/6J) 
Animal facility at the  
University Hospital Jena  
(Research centre Jena) 
 
 
2.1.3. Bacterial vectors 
The following bacterial vectors were used in order to clone the targeting construct to produce 
KI mouse lines. 
Table 2.2 Vectors used for cloning of the targeting vectors 
Vectors Notes 
pBluescript SK (+/–) Stratagene 
pKO Scrambler 901 Stratagene 
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2.1.4. Antibodies 
Following antibodies and their respective working concentrations for Western blotting and/or 
immunohistochemistry experiments were used. 
Table 2.3 Antibodies used for Western Blotting and Immunohistochemistry 
 Working concentration  
Antibodies Western Blot Immunohistochemistry Source 
anti Pendrin guinea pig 1:20000 1:1000 Prof. Wagner Lab Zurich 
anti Pendrin rabbit 1:20000 1:1000 Prof. Wagner Lab Zurich 
anti AE 1 guinea pig 1:20000 1:1000 Prof. Wagner Lab Zurich 
anti AE 1 rabbit 1:20000 1:1000 Prof. Wagner Lab Zurich 
v-ATPase B1/2(H-180) 1:1000 1:500 Santa Cruz Biotechnologies 
anti β-actin 1:1000  Santa Cruz Biotechnologies 
ECL mouse IgG, HRP-
Linked (from sheep) 
1:4000  Amersham(GE healthcare) 
ECL rabbit IgG, HRP-
Linked (from donkey) 
1:4000  Amersham(GE healthcare) 
anti-guinea pig IgG Alexa 
Fluor 488 
 1:1000 Molecular probes Invitrogen 
anti-rabbit IgG Alexa 
Fluor 488 
 1:1000 Molecular probes Invitrogen 
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2.2. Methods 
2.2.1. Microbiology methods 
2.2.1.1. Preparation of chemocompetent bacteria 
The preparation of chemo competent bacteria was started with a preculture of E. coli XL1 
Blue in 2 ml  broth medium (LB-broth medium, 4 mM MgSO4, 10 mM KCl, 3 µg / ml 
tetracycline adjusted to pH 7.0 and autoclaved), grown overnight at 37 ° C while shaking. The 
next morning, 500 ml  broth medium was inoculated with 1 ml of the preculture and grown 
at 37 ° C with shaking until an optical density of 600 nm (OD600) of 0.3-0.6 was achieved. 
After removal of the culture from the incubator, the bacteria were cooled on ice and pelleted 
in a centrifuge (Beckman) at 3000 rpm for 5 minutes at 4 ° C.  The supernatant was discarded 
and the pellet was resuspended in 150 ml icecold TFB1 buffer (15% glycerol, 10 mM CaCl2, 
30 mM potassium acetate, 100 mM RbCl, 50 mM MnCl2, pH 5.8 adjusted with CH3COOH) 
and incubated on ice for 60 minutes. After incubation on ice the bacterial suspension was 
centrifuged again at 3000 rpm for 5 minutes at 4 ° C. 
The supernatant was discarded and the pellet was resuspended in filtered sterile, ice-cold 
TFB2 buffer (15% glycerol, 10 mM MOPS, 75 mM CaCl2, 10 mM RbCl), by pipetting. The 
competent cells were divided into aliquots on ice (300 µl). The aliquots were immediately 
snapfrozen in liquid nitrogen and stored at -80 °C until use. 
2.2.1.2. Transformation of competent bacteria 
An aliquot of chemocompetent bacteria was thawed on ice, and the plasmid DNA to be 
transformed was mixed with 50µl of competent bacteria and incubated on ice for 20 minutes. 
To induce the uptake of the plasmid the bacteria was given a heat shock at 37°C for 2 
minutes. After a brief cooling on ice, 300µl of SOC medium (0.5% yeast extract, 2% tryptone, 
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose, pH 7.0)  was 
added and incubated at 37°C on shaker for 45 minutes. The bacteria were then pelleted by 
centrifugation at 4000rpm for 5 minutes. 300 µl of supernatant was removed and the pellet 
was resuspended in the remaining SOC medium. The suspension was plated out on LB-Agar 
plates containing the appropriate antibiotic. The inverted plates were incubated at 37 °C 
overnight. 
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2.2.1.3. Screening of lambda phage library 
To prepare the targeting vectors for generation of transgenic mice by homologous 
recombination DNA fragments of 15-25 kb containing the desired gene are necessary. To 
obtain such a genomic DNA fragment a phage library (Lambda FIX II, Stratagene) was used. 
The phage library carries the bacteriophages with incorporated mouse genomic DNA 
fragments flanked by the phage genome. Isolation of the mouse genomic fragment carrying 
the desired gene was done with the help of a radiolabelled probe binding to the exons of 
interest of the particular gene. 
The screening of phage library is based on transduction principle in which, mixture of phages 
and bacteria were grown on agar plates. The DNA is subsequently transformed to a positively 
charged nylon membranes with a high binding capacity for nucleic acids. These membranes 
were hybridized with radiolabelled probe generated against part of specific genomic 
fragments and analysed to obtain genomic fragments of gene of interest to use for further 
cloning in bacteria. 
E. coli XL-1 Blue MRA bacteria were grown at 37 °C in 100 ml LB medium containing 0.2% 
maltose and 10 mM MgSO4 until the optical density of OD600 = 1 was achieved. Maltose is 
an essential part of the medium as it helps to transduce bacteria via the Maltose receptor of  
phage. The MRA bacteria were pelleted by centrifugation at 3000 rpm for 15 minutes at 4 °C. 
The bacterial pellet was washed with 10 mM MgSO4 and resuspended again in 20 ml of 10 
mM MgSO4 and stored at 4°C for up to 2 weeks.  
The screening of the  phage library was carried out in two different steps and by using two 
different sizes of agar plates. 150 mm plates were used for the entire library at first step as 
well as at the end for preparative isolation of a bacterial clone carrying the DNA fragment of 
interest and 90 mm plates were used for the further enrichment of clones with the desired 
fragment of genomic DNA. 450 µl and 150µl of MRA bacterial suspension were used for 150 
and 90 mm plates respectively. 150 µl or 450µl of MRA bacterial suspension was incubated 
with (a predetermined titrated amount of)  phages at 37 °C on shaker for 20 minutes.  
This bacterial-phage mixture was added to 9 ml (150 mm plate) or 3 ml (90 mm plate) pre-
melted (at 47 ° C in water bath) 1% agar LB medium, mixed well and the top agar was spread 
evenly on pre-warmed agar plates of the respective size. The resulting plates were dried for 
about 15 minutes at room temperature and incubated at 37 °C overnight. 
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After overnight incubation, plates grown with plaques were cooled to 4 °C, so that nylon 
membrane (Biodyne A0.45 microns, 82 and 132 mm, Pall Life Sciences) can easily be used to 
transfer the plaque DNA on top agar. Membranes were incubated with cooled plates for 1-2 
minutes, during this time a sharp scalpel was used to cut the membrane together with agar at 3 
different positions to give an orientation to incubating membranes for later analysis.  
After this short incubation DNA side of membranes lying upside down were treated with 
denaturing buffer (1.5 M NaCl, 0.5 M NaOH) and with neutralization buffer (1.5 M NaCl, 0.5 
M Tris, pH 8.0) for 2 minutes and 5 minutes respectively. The membranes were then 
incubated for 1 minute in wash buffer (0.2 M Tris, 2X SSC) and air-dried. The DNA was 
fixed on membranes by baking at 80 °C for 2 hours. 
To find out positive clones carrying the desired gene fragment from the  phage library the 
membranes were hybridized with respective radioactively labelled probe (see Section 
molecular biology). After hybridization and subsequent washing, membranes were exposed to 
X-ray films to visualize the signal indicating the presence of positive clones. Agar plates were 
place on the X-ray films with the correct orientation and pieces of agar were removed as 
single clones according to the location of signal. Agar pieces with positive clones were 
suspended in 1 ml SM buffer (5.8 g NaCl, 2 g MgSO4.7H2O, 50 ml Tris-HCl pH 7.5, 5 ml 2% 
gelatine in 1L H2O) with 20 µL of chloroform and incubated overnight at 4 °C after 
vortexing. 
After overnight incubation the mixture containing agar pieces was diluted 1:1000 times to 
ultimately isolate a single clone in another round of selection, 1µl of this dilution were 
incubated with 10, 100 and 150μl of MRA bacteria for 20 minutes at 37 °C with shaking. 
Mixture of phage clones with MRA bacteria was added to 3 ml (90 mm plate) pre-warmed 
1% agarose in LB medium at 47 °C and evenly spread on a LB plate. The resulting plates 
were dried for 15 minutes at room temperature and then incubated at 37 °C overnight. 
Membranes were incubated again with plates as mentioned above by following the same 
procedure to ultimately isolate a single phage clone with the DNA fragment of desired gene. 
Once the single phage clones were obtained, the titer of the phage suspension was determined 
and 150 mm plates were used to prepare the DNA (see DNA preparation of  phage). 
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2.2.2. Molecular biology methods 
2.2.2.1. Cloning of targeting vector 
2.2.2.1.1. Restriction digest 
In order to clone existing DNA or newly synthesized PCR products, restriction digest of 
plasmid or genomic DNA was performed by using restriction enzymes with the respective 
buffers from Fermentas and New England Biolabs. For the cloning of DNA fragments into 
appropriate vector, 1-2 µg of insert and 5 µg of vector were digested with 10 units of the 
respective restriction enzymes and incubated overnight at 37 °C in order to achieve a 
complete digestion.  
Special conditions were applied to digest DNA for Southern blots. 5-10 micrograms of 
genomic DNA with 20-30 units of restriction enzyme was incubated at the respective 
temperature overnight. The next morning 10 units of enzyme was added and incubated for at 
least 1 hour to further enhance the restriction digest efficiency. 
2.2.2.1.2. Blunting of sticky ends and dephosphorylation 
To fill the DNA overhanging ends (blunting of sticky ends) T4 DNA polymerase was used. 
Before starting the filling of overhanging ends, restrictions enzymes were deactivated by 
heating at 65 or 80 °C for 20 minutes and after cooling on ice, 1 µl of 10 mM dNTPs and 1 µl 
T4 DNA polymerase (Fermentas) was added and incubated at 12 °C for 20 minutes. Finally, 
the T4 DNA polymerase was inactivated at 75 °C for 20 minutes. Dephosphorylation of 
restricted vectors was done by alkaline phosphatase (Roche). For this purpose the restriction 
enzymes were inactivated by heating and then incubated with 1µl of Calf Intestine Alkaline 
Phosphatase for 60 minutes at 37 °C. Vector DNA was purified by gel electrophoresis after 
heat inactivation at 75 °C. 
2.2.2.1.3. Agarose gel electrophoresis 
Separation of DNA fragments from PCR reactions or restriction digests was achieved by 
horizontal gel electrophoresis carried out in agarose gel chambers (Amersham Biosciences). 
Agarose concentrations between 1 and 2% were used depending on the respective DNA 
fragment size. Agarose was boiled in 1X TAE buffer (40 mM Tris-acetate, 1 mM EDTA), and 
prior to pouring the gel, 0.5 µg / ml ethidium bromide was added.  
For gel loading the DNA samples were mixed with 6X DNA loading buffer (10 mM Tris-
HCl, 30% glycerol, 0.25% bromophenol blue, 0.25% xylene cyanol). The DNA fragments 
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were separated in 1X TAE by applying a constant voltage between 30 - 150 V depending on 
the desired separation time. After separation the DNA fragments were visualized under UV 
light.  
2.2.2.1.4. DNA ligation 
In order to create the desired plasmid constructs, insert and vector fragments with compatible 
ends were ligated to each other. Ligation efficiency depends on various factors, such as 
complete digestion of the respective restriction fragments as well as the ratio between insert to 
vector. This ratio was determined by molecular weights of respective DNA fragments and 
their concentration in the ligation mixture. Such ratios were adjusted accordingly to insert a 
20-30 bp linker or a few kb fragments into a vector. 
For a typical ligation mixture, 1µl of vector, 2µl of 10X ligation buffer, 1µl of T4 DNA 
Ligase (New England Biolabs) and respective amount of a DNA fragment to be ligated was 
added and the final volume of 20 µl was adjusted with H2O. Ligation mixture was incubated 
overnight at 4°C and 2-5 µl of this ligation mix was used to transform chemocompetent 
bacteria. 
2.2.2.1.5. DNA sequencing 
In order to verify that the reading frame and the nucleotide sequence of cloned constructs as 
well as for the analysis of the point mutation created in targeting vector or knock in mice, 
DNA sequencing was performed. For sequencing reactions 1µl of plasmid or 1µl of mouse 
genomic DNA was added in a 0.2 ml tube, along with 10 pmol of the sequencing primers, 2µl 
of sequencing buffer, 1 µl of Big Dye (ABI) and H2O up to 10µl. In a thermocycler the 10 μl 
reaction was subjected to the following sequencing program cycle. 
Table 2.4 Cycling temperatures and duration of Sequencing PCR 
 
 
 
 
 
After completion of the reaction, the DNA was precipitated by adding 1/10th vol. of 3 M Na 
Acetate (pH 5.5) and 2.5 vol. of ethanol, and centrifuging for 10 min at 14000 rpm. After a 
Step Temperature Time 
Initial denaturation 96°C 60 sec 
Denaturation 96°C 10 sec 
Annealing 55°C 8 Sec 
Elongation 60°C 4 min 
 4°C ∞ 
These steps were 
repeated for 28 times. 
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70% (v/v) ethanol wash, the pellet was dried and solved in 10µl of Hi-Di™ Formamide (ABI) 
for further analysis. 
2.2.3. Isolation and purification of nucleic acids 
2.2.3.1. Isolation of DNA from -phage 
Mouse genomic DNA was purified from -phage grown on three fully lysed plates with large 
plaques. After cooling the plates to room temperature, 10 ml of SM buffer was added to each 
plate and incubated overnight at 4 °C with gentle shaking. The supernatant from all three 
plates was collected in a 50 ml falcon and 1 ml of chloroform was added in the tube. After 
vigorous vortexing bacterial cell debris were pelleted by centrifuging at 4000 g, for 15 
minutes at 4 °C. 
Beckman Ultra-Clear centrifuge tubes (25x89 mm) were used for CsCl density gradient 
purification of phage DNA. 25 ml of the supernatant was taken into the tube containing 3 ml 
of 3 M CsCl (prepared in SM buffer) forming the bottom layer and 5 ml of 5 M CsCl 
(prepared in SM buffer) making the upper layer. Special attention needs to be taken for 
layering the different concentration of CsCl over the phage suspension to prevent the mixing.  
The centrifuge tubes were centrifuged at 25,000 rpm for 2 hours at 20 ° C with a SW28 rotor 
in a Beckman ultracentrifuge, after careful balancing the weight. The lower band carrying the 
-phage was collected with a syringe by puncturing the Beckman Ultra-Clear centrifuge tube 
and filled up to 5ml by adding 5M CsCl. 
This final 5 ml mixture was transferred to a smaller Beckman Ultra-Clear centrifuge tube 
(14x89 mm,) and overlaid with 3.5 ml of 5 M CsCl in SM buffer followed by 4.5 ml of 3 M 
CsCl in SM buffer. The sample tubes were centrifuged in Beckman centrifuge at 35,000 rpm 
for 90 minutes at 20 °C in a SW40T1 rotor. The lower band with the -phage was taken in a 
volume of 600-900 µl by puncturing the tube in a syringe and divided into aliquots of 150 µl. 
15 µl of 2 M Tris-HCl, 0.2 M EDTA, pH 8.5, and 150 µl of formamide was added into 150 µl 
of phage suspension and after mixing well incubated at room temperature for 30 minutes. 
Phage DNA was precipitated by adding 150 µl of H2O followed by 900µl of 100% ethanol. 
Precipitated DNA was washed in 70% ethanol and dissolved in 150µl of TE buffer overnight 
at 4 °C. 
The desired fragment of the mouse genomic DNA was isolated from phage DNA by 
restriction digestion and gel electrophoresis. To separate the mouse genomic DNA fragment 
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from phage DNA, NotI or SalI were used as restriction enzymes and a long 0.8% agarose gel 
with bigger loading pockets was run overnight at 40V, due to bigger molecular weight and 
size of these genomic DNA fragments. At the end, the mouse genomic DNA fragment was 
purified from agarose gel and subsequently cloned into a bacterial vector. 
2.2.3.2. Mini preparation of plasmid DNA bacterial clones 
A single bacterial colony was inoculated in 3-5 ml of LB containing 50 mg/ml of Ampicillin 
in a sterile culture tube. The culture was grown overnight at 37 °C with shaking (180 rpm), 
after which 1.5 ml of the culture was transferred to an Eppendorf tube. The bacteria were 
collected by centrifugation and the  ellet was resus ended in 100 μl of P1 buffer (50 mM 
glucose, 25 mM Tris- Cl    8.0, 10 mM EDTA, 100 μg/ml RNase A). Alkaline lysis of the 
bacteria was  erformed by adding 200 μl of P2 buffer (200 mM NaO , 1 % SDS w/v) and 
gently mixing the tubes by inversion. After a short incubation on ice, 150 μl of P3 Buffer (5.0 
M, Potassium Acetate pH 4.8) was added and the tubes were gently inverted several times to 
mix. Removal of the precipitated proteins from the lysate was achieved by a 5 min 
centrifugation at 14000 rpm. The supernatants were transferred to new 1.5 ml tubes and 900 
μl of 100% ethanol were added. The  lasmid DNA was  reci itated by centrifugation at 
14000 rpm for 5 min. DNA pellets were washed once with 70 % (v/v) ethanol, allowed to dry, 
and dissolved in TE or water. 
2.2.3.3. Midi preparation of plasmid DNA 
Applications like electroporation of targeting construct into embryonic stem cells with 
plasmids require highly pure and intensely supercoiled DNA. To achieve this quality of 
plasmid DNA, it was prepared using the Midi Kit from Qiagen according to manufacturer's 
instructions.  
2.2.3.4. Slot lysis  
Slot lysis was performed to analyse the insertion of DNA fragments  500bp to a vector after 
ligation. This offers a quick and inexpensive way to check a large number of clones to make a 
preliminary selection of clones with insert. The principle of slot lysis is based on the lowered 
running speed of DNA clones carrying the insert during the gel electrophoresis. If a clone is 
identified with the successful insertion of a respective DNA fragment the remaining volume 
of bacterial culture was used for a mini-DNA extraction and clone was further analysed by 
restriction digests and DNA sequencing. Slot lysis was performed in a 96-well plate, 100 µl of 
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bacterial culture was added to the plate and bacteria were pelleted by centrifugation at 4000 
rpm for 10 minutes. 
The bacterial pellets were resuspended in 20 µl of protoplast buffer (30 mM Tris-HCl, 5 mM 
EDTA, 50 mM NaCl, 20% sucrose, 50 g/ml RNase, 50 mg / ml lysozyme). Gel pockets were 
loaded with the 14 µl lysis buffer (89 mM Tris-HCl, 89 mM boric acid, 2.5 mM EDTA, 2% 
SDS, 5% sucrose, 0.04% Bromophenol Blue) and bacterial mixture (20µl) was added. 
Bacteria were lysed and the plasmid DNA was separated in an electric field according to size. 
2.2.3.5. Purification of DNA from an agarose gel 
Under UV light, the DNA bands were excised from the agarose gel using a sharp scalpel and 
placed in to a 1.5 ml tube. The DNA was purified by using the DNA recovery kit (Zymoclean, 
USA) according to the manufacturer's instructions. 
2.2.3.6. Purification of DNA for ES cell culture 
For electroporation of the targeting construct into embryonic stem cells for homologous 
recombination, linearized DNA with the highest quality was needed. For this purpose 80-
100µg of purified DNA was digested with 80-100 units of NotI restriction enzyme in final 
volume of 250 µl overnight at 37 °C. 10-20 units of the same enzyme was used next morning 
to incubate further for 2 hours at 37°C to increase the efficiency of DNA digestion. 2µl of an 
aliquot was used to check the complete linearization of the targeting construct by gel 
electrophoresis. 
After successful digestion of the DNA the remaining digestion mixture was added up to 
volume of 500µl with H2O. Then, 1 volume of TE-buffered phenol-chloroform-isoamyl 
alcohol mixture (25:24:1, Roth, Karlsruhe) was added and mixed briefly by gently inverting 
the tube several times. The DNA sample was centrifuged at 13,000 rpm for 10 minutes at 4 
°C and upper aqueous phase was taken into new tube. After two times washing with 
chloroform-isoamyl alcohol (24:1) to remove the remains of phenol, DNA was precipitated by 
adding 1 volume of isopropanol and 1/10 vol. of 3 M sodium acetate pH 5.2. The precipitated 
DNA was washed with 70% ethanol, air dried and dissolved overnight in ES cell culture 
grade pure H2O. DNA concentration was measured by Nano-drop and adjusted to the 
concentration of 1µg/µl. 
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2.2.3.7. Phenol-chloroform extraction of mouse genomic DNA from tail biopsy 
Phenol-chloroform extraction was performed for the purification of mouse genomic DNA 
from the mouse tail biopsy. A tail biopsy of 0.2 to 0.3 cm was taken and incubated overnight 
in 500 µl lysis buffer (50 mM Tris, 100 mM EDTA, 100 mM NaCl, 1% SDS, pH 8.0) 
supplemented with 10 µl  of proteinase K (14mg/ml) at 55 °C.  
After cooling the lysate one volume of TE-buffered phenol-chloroform-isoamyl alcohol 
mixture (25:24:1, Roth, Karlsruhe) was added and mixed by rotating the sample for 5 minutes 
at room temperature. The DNA sample was centrifuged at 13,000 rpm for 10 minutes at 4 °C 
and upper the aqueous phase was transferred into new tube. After two times washing with 
chloroform-isoamyl alcohol (24:1) to remove the remains of phenol, DNA was precipitated by 
adding 1 volume isopropanol and 1/10 vol. 3 M sodium acetate pH 5.2. The precipitated DNA 
was washed with 70% ethanol, air dried and dissolved in 150µl of TE buffer overnight at 4 °C 
and stored until use at 4 °C. This DNA was further used for genotyping PCR and Southern 
blot. 
2.2.3.8. DNA extraction from mouse tail biopsies by hot-shot method 
Genomic DNA extraction was also performed from tail biopsies of mouse by a faster method 
called Hot-Shot to analyse mouse genotypes by polymerase chain reaction. A tail biopsy of 
0.2 to 0.3 cm was taken and incubated in 75 µl of alkaline lysis buffer (25 mM NaOH, 0.2 
mM EDTA, pH 12.0 without setting) for 60 minutes at 95 ° C. After briefly cooling down the 
sample on ice, 75 µl of the neutralization buffer (40 mM Tris-HCl, pH 5.0 without 
adjustment) was added and stored at 4 °C for further PCR analysis of mouse genotype. 
2.2.3.9. Purification of RNA from mouse tissues 
Trizol (Invitrogen) was used for isolation of RNA from mouse tissues. Tissues were removed 
from anesthetized mouse after perfusion with 1X PBS (137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 2 mM KH2PO4). Removed tissues were ground in liquid nitrogen with a mortar and 
pestle and transferred into a 50 ml falcon with little bit of liquid nitrogen, 1 ml Trizol per 100 
mg tissue was added after liquid nitrogen had evaporated.  
Samples were vortexed briefly and incubated for 5 minutes at room temperature. To pellet the 
cellular debris tissue samples were centrifuged for 5 minutes at 4000g at 20 °C and the 
supernatant was transferred to a new tube. 200µl of chloroform per 1 ml Trizol was added and 
shaken vigorously by hand for 15 seconds.  
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Afterwards samples were incubated for 2 minutes at room temperature and then centrifuged at 
13,000 rpm at 4 °C for 15 minutes. The aqueous (upper) phase was transferred into a new 
tube and RNA was precipitated by adding 1 volume of isopropanol. This mixture was 
incubated for 10 minutes at RT and centrifuged at 13000 rpm at 4 °C for 10 minutes. The 
resulting RNA pellet was washed with 75% ethanol, air dried, and carefully dissolved in 
RNase free water and stored at -80 °C until further use. 
2.2.4. Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) was performed for the amplification of DNA fragments of 
interest, for cloning of southern and northern blot probes as well as for the genotyping of 
transgenic mice. The Taq DNA polymerase (Invitrogen, USA) was used to amplify smaller 
DNA fragments (up to 1Kb). For longer DNA fragments (> 1000bp) Expand polymerase 
(Roche) was used. A ty ical reaction was  erformed in a volume of 25 μl with 0.1 -1 μg of 
tem late, 1x of reaction buffer (Invitrogen), 10  mol of each  rimer, 0.5 mM of each dNTP’s 
(Invitrogen) and 0.1µl of Taq DNA polymerase. 
The reactions were performed either in the T-Gradient PCR machine or the T3000 thermo 
cycler from Biometra. A standard PCR reaction protocol given in the following table, 
however, annealing temperatures and elongation times were calculated specifically for each 
primer pair. If the PCR product generated was subsequently used for cloning, the entire 
reaction was loaded on a gel for electrophoresis. The PCR product was excised from the gel 
and purified prior to restriction enzyme digest. 
Table 2.5 Typical PCR cycling temperatures and duration 
 
 
 
 
  
 
 
 
Step Temperature Time 
Initial denaturation 95°C 5 min 
Denaturation 95°C 30 sec 
Annealing 55-60°C 30 Sec 
Elongation 72°C 1 min/1000bp 
 4°C ∞ 
These steps were 
repeated for 35 times. 
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2.2.4.1. Genotyping PCR 
Genotyping PCR was performed on DNA isolated from mice tail biopsies. Genotyping of 
both KI mice (R607H & L919X) was done in a reaction mixture containing 3 primers that 
allows controlling the removal of neo selection cassette after cre-recombination. A typical 
reaction was  erformed in a volume of 25 μl with 0.1 -1 μg of tem late, 1x of reaction buffer 
(Invitrogen), 10 pmol of each primer, 0.5 mM of each dNTP (Invitrogen) and 0.1µl of Taq 
DNA polymerase (Invitrogen). The reactions were performed either in the T-Gradient PCR 
machine or the T3000 thermo cycler from Biometra. 
 
Figure 2.1 Genotyping scheme of R607H Knock In mice 
 
 
Figure 2.2 Genotyping scheme of L919X Knock In mice 
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Table 2.6 List of Primers used for genotyping, mutagenesis and real-time PCR 
Genotyping primers 
L919X 
Sequence (5’-3’) 
L919X Geno F  GTC TCC GTC TTG GTC TGC TGT G 
L919X Geno R  TGG ACA AGC CCT GCT GTC CCT A 
Neo Cassette R  GGG GCC ACC AAA GAA CGG AGC CGG 
Genotyping primers 
R607H  
 
R607H Geno F  TAG CTC CTT CTA CCC CAC CCA 
R607H Geno R  CCA GAG GTA CAT GGT AAA ACA TTG TC 
Floxed Neo R  GGA AGA CAA TAG CAG GCA TGC  
Mutagenesis Primers 
R607H 
 
R607H Mut F CTTGCCATGACGCTACATAAGTTCAAGAACAGC 
R607H Mut R  GCTGTTCTTGAACTTATGTAGCGTCATGGCAAG 
Mutagenesis Primers 
L919X 
 
L919X Mut F CCTTTGACGAGGAGAATGGCTAGGATGAATATGACGAAGTGC 
L919X Mut R  GCACTTCGTCATATTCATCCTAGCCATTCTCCTCGTCAAAGG 
Real Time Q-PCR 
Primers 
 
Ae1-RT PCR1F   GGC ACC TAC ACA CAG AAA C 
Ae1-RT PCR1R   GGA GGC AAA CAT CAT CCA C 
Ae1-RT PCR2F   AGG ACC TGG TGT TGC CAG AG 
Ae1-RT PCR2R   CGG TTA TGC GCC ATG GA 
 
 
2.2.4.2. Reverse transcription  
RNA concentration was determined by absorption of the sample at 260 nm with Nano-drop 
device (Thermo Scientific, USA). 500 ng of RNA was used for reverse transcription. At first 
stranderd complementary DNA (cDNA) synthesis was performed using random 
hexanucleotide primers and Superscript III kit according to the manufacturer’s instructions 
(Invitrogen, USA). Final cDNA was diluted to 50 ng/µl and stored at -20°C.  
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2.2.4.3. Real time Q-PCR  
Complementary DNA (cDNA) of kidney cortex and medulla, primers (see table 2.6) and the 
SsoFast EvaGreen Supermix (Bio-Rad Laboratories GmbH) were used for quantitative real 
time PCR with the CFX96 real time system (Bio-Rad Laboratories GmbH). Actin was used as 
a housekeeping gene. All PCR reactions were coupled to melting-curve analysis to confirm 
the amplification specificity. The relative quantification was calculated with the analysis 
software that was provided by the Bio-Rad laboratories.  Transcript abundance in the mouse 
kidney tissue was analysed.  
2.2.5. Cell biology methods  
2.2.5.1. Mouse embryonic stem cell culture and blastocyst injection 
Mouse embryonic stem cell culture and blastocyst injection was done by core unit of 
transgenic mice production in the university hospital Jena. 
2.2.6. Southern blot 
For southern blot analysis, DNA prepared from embryonic stem cells or genomic DNA of the 
mouse was taken (10 to 50 µg) and digested overnight with 20-30 units of a restriction 
enzyme (Fermentas) at the appropriate temperature. The resulting fragments were separated 
by a 0.8% agarose gel electrophoresis and ethidium bromide was used to visualize under UV 
light and documented. To facilitate the transfer of large DNA fragments to a nylon membrane 
(Hybond XL, GE Healthcare) the gel was washed several times with distilled water and 
incubated with 0.25 M HCl for 15 minutes. After repeated washing with distilled water, the 
gel was equilibrated in 0.4 M NaOH for 15 minutes and a capillary blot was built with 0.4 M 
NaOH for overnight. After blotting overnight the nylon membrane was baked for 2 hours at 
80 °C to immobilize the DNA on the membrane. Membrane was briefly washed in 2X SSC 
before hybridizing with the radiolabelled probe. 
2.2.7. Radio-labelling of probes with 
32
P 
32
Phosphorous dCTP was used to label the probes. Prior to labelling the DNA fragment (300-
700 bp) used as probe was cut out from a plasmid with the help of a suitable restriction 
enzyme. 25-50 ng of this gel purified DNA fragment was dissolved in 45µl of TE buffer and 
denatured at 95 °C for 5 minutes.  
After cooling on ice the sample was briefly centrifuged and the contents of the denatured 
probe was transferred into a Rediprime II (GE Healthcare, USA) tube containing lyophilized 
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dATP, dTTP, dGTP and DNA polymerase. At the end 5µl of 
32
P-dCTP was added and mixed 
well by pipetting. The reaction mixture was incubated for 30 minutes at 37 °C. 
For purification of unbound radiolabelled nucleotides, probe mix was added on the top of a 
G50 column (GE Healthcare, USA) and purified according to the manufacturer’s instructions. 
Radiolabelling efficiency of the probe was measured with a Beckman scintillation counter by 
taking 1µl aliquot of labelled probe. The final activity in the hybridization mix (7% SDS, 10% 
PEG, 1.5 x SSPE, 0.1 mg/ml fish sperm DNA (Roche)) was set to 500000 cpm/ml.  
Prehybridization of the respective membrane was done for 2 hours at 68 °C in pre-
hybridization mix (7% SDS, 10% PEG, 1.5 X SSPE, 0.1 mg / ml fish sperm DNA (Roche)) to 
reduce the nonspecific binding of the probe to the membrane. The membrane was hybridized 
with the radio-labelled probe overnight at 68 °C. The membrane was washed twice with 
preheated washing buffer (2X SSC, 0.1% SDS) at 68 °C for 20 minutes. Membrane was 
wrapped in thin plastic film and placed in a cassette for overnight exposure to a 
phosphorimager plate (Fuji Films, Japan). The PhosphoImage Analyzer (FLA-3000 Series, 
Fujifilm) was used for analysis. 
2.2.8. Biochemical techniques 
2.2.8.1. Preparation of proteins 
2.2.8.1.1. Cytosolic membrane preparation 
Cytosolic proteins were prepared by grinding mouse tissues in a mortar with a pestle with 
liquid nitrogen and by adding 10-fold volume of lysis buffer (3% SDS, 30 mM Tris, 5 mM 
EDTA, 30 mM NaF, 10% glycerol, pH 7.4, complete protease inhibitor cocktail (Roche)). 
This mixture was further homogenised in glass potter (Potter S, Sartorius) and pelleted by 
centrifugation at 13,000 rpm, 4 °C for 10 minutes. The supernatant containing cytosolic 
proteins was transferred to a new tube, the protein concentration was determined by the BCA 
method (Pierce kit) and aliquots were frozen (2µg/µl) in 1 X Laemmli buffer at -80 °C. 
2.2.8.1.2. Membrane protein preparation 
Frozen tissues taken from PBS perfused mice were taken and grinded with mortar and pestle 
in liquid nitrogen and transferred to a 50 ml Falcon. 1 ml of Homogenization buffer (0.25% 
sucrose, 10 mM Hepes, 1 mM EDTA, pH 7.4 complete with protease inhibitor cocktail 
(Roche))  for 200mg tissue was added and the tissue was homogenized in a glass potter 
(Potter S, Sartorius). Cell debris was separated by centrifugation at 800 g, 4 ° C for 5 minutes 
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and the supernatant was transferred to a new tube. The supernatant obtained was centrifuged 
to pellet the cellular organelles and mitochondria at 10,000 g, 4 ° C for 15 minutes. 
Membrane proteins were pelleted by centrifugation of the supernatant in polycarbonate 
centrifuge tubes (Beckman) at 110000 g, 4 ° C for 1 hour and incubated overnight at 4 °C in 
sample buffer (50 mM NaCl, 1 mM EDTA, 0.75% Triton, 1% Chaps, 10% glycerol, pH 7.5 
complete protease inhibitor cocktail (Roche)). The protein concentration was determined by 
the BCA method (Pierce kit) and aliquots were frozen (2µg/µl) in 1 X Laemmli buffer at -80 
°C. 
2.2.8.2. Western blot 
A semi quantitative analysis of protein expression was performed by Western blotting. For 
this purpose proteins were separated based on their molecular weights on a SDS 
polyacrylamide gel, made up of an upper 5% stacking gel and lower 8-10 % polyacrylamide 
running gel. The Bio-Rad Mini-PROTEAN 3 system was used for casting and running of the 
gel. Before loading the gel, 20-30µg of protein was denatured in 1x Laemmli buffer at 60 ° C 
for 10 minutes and cooled on ice. Denatured proteins were loaded to the SDS polyacrylamide 
gel and separated according to their size by electrophoresis in a running buffer (25 mM Tris, 
250 mM glycine, 0.1% SDS).  
Proteins were transferred to a nitrocellulose membrane (PROTRAN, Whatman) by wet 
electro blotting system in a transfer buffer (Glycine 39 mM, 48 mM Tris, 0.037% SDS, pH 
8.3 ) on ice at 400 mA over 70 minutes. Membranes were analysed for transfer of the proteins 
with Ponceau-S staining and subsequent washing with distilled water. 
Detection of protein expression was done by using specific antibodies. For this purpose 
membranes were briefly washed with 1X TBST (150 mM NaCl, 50 mM Tris, 0.02 % (v/v) 
Tween 20; pH 7.9) and incubated with blocking buffer (5% skimmed milk powder in TBST) 
for 1-2 hours at room temperature followed by incubation with the primary antibody in 
blocking buffer at 4 °C overnight. The membrane was washed 3 times in 1X TBST for 10 
minutes each. Then membranes were incubated with the secondary antibody coupled with 
horseradish peroxidase (HRP) in TBST for 1-2 hours at room temperature. Membranes were 
washed again 3 times in TBST and the HRP-coupled secondary antibody was detected by 
enhanced chemiluminescence on an X-ray film (ECL, Millipore). 
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2.2.8.3. Immunohistochemistry 
In order to visualize the localization of the proteins of interest, immunohistochemial analysis 
of mouse kidneys were performed. Mice were anaesthetised by intraperitoneal injection of 
(2ml ketamine (50mg/ml), 0.7 ml Rompin (2%) in 5.6 ml 0.9 % NaCl) according to body 
weight (20g ≈ 100µl) before  erfusion. Transcardial perfusion was performed in anaesthetized 
adult mice (WT or KO, 6-8 weeks of age) with 4% PFA in 1X PBS. 
Kidneys were removed and post fixed in 4 % PFA in 1X PBS for 2 hours at room temperature 
followed by 3 times washing with 1X PBS. Kidneys were dissected in 2 halves in transverse 
manner and incubated in 30% w/v sucrose solution in 1X PBS for 2-3 days at 4 °C for 
cryoprotection. Kidneys were frozen in OCT compound (Tissue-Tek, USA) and 7 µm 
cryosections were cut in a cryotome (- 24 °C, Leica, Germany). 
Rehydration was performed by washing the sections with 1X PBS for 15 minutes at room 
temperature and antigen retrieval was done by treating the sections with 1% SDS in PBS for 5 
minutes. Slices were washed 3 times in 1X PBS for 5 minutes each and were subsequently 
blocked in blocking buffer (1%BSA in 0.02 % sodium azide PBS) for 30 minutes at room 
temperature. The primary antibody was applied in the specific working dilution in 0.02 % 
sodium azide PBS solution for overnight at 4 °C. Hypertonic PBS (1X PBS + 18g NaCl per 
litter) was used to wash sections 2 times each for 5 minutes followed by 1X PBS. Slices were 
stained with fluorescently labelled secondary antibodies (Alexa Fluor 488- and 555-coupled 
goat anti-rabbit, goat anti-guinea pig, Invitrogen) diluted 1:1000 in 0.02 % sodium azide PBS 
at room temperature for 1 hour. Sections were washed with Hypertonic PBS for 2 times each 
for 5 minutes followed by 1X PBS wash. Cell nuclei were stained by 4',6-diamidino-2-
phenylindole (DAPI; 1µg/mL) and sections were analysed by confocal microscopy (Leica 
TCS SP5, Germany). 
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2.2.9. Animal experimentation 
2.2.9.1. Metabolic cage studies 
All metabolic cage studies of both KI mice lines were performed in the animal facility of the 
University hospital Jena according to the permission from local laboratory animal welfare 
institute. Mice were housed at a constant room temperature (24±1 °C) with 12-h light/dark 
cycle. For convenience, the 12:12 light/dark cycle was inverted. Mice were given deionised 
water ad libitum and pair-fed with standard laboratory chow. 
All experiments were performed on male mice (R607H KI and L919X KI) of 2 to 3 months of 
age. Animals were housed in metabolic cages (Techniplast, Italy) and the intake of food and 
water as well as body weight were monitored throughout the experiment.  
Urine collection was performed daily under mineral oil in the urine collector for urine pH 
measurements as well as the urine electrolytes concentration. After one week on deionised 
water mice were give a pulse of 0.28 M NH4Cl solution for 24 hours to study the acid 
secretion efficiency of both KI mice verses WT control.  
The urine pH and creatinine concentration was determined in the department of clinical 
chemistry University hospital of Jena.  
Blood was taken in heparin-treated capillary tubes retro-orbitaly and immediately analysed for 
pH, pCO2 and pO2 on independent mice cohort with ABL 77 blood gas analyser 
(Radiometer, Denmark).  
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3. Results 
Mutations of the anion exchanger 1 (AE1) are the major cause of hereditary distal renal 
tubular acidosis. The point mutation R589H and the c-terminal 11-amino acid truncation 
R901X are two familiar mutations in the human AE1 gene. These mutations were chosen to 
generate two independent knock in (KI) mouse models. The R607H mice correspond to the 
human R589H and L919X mice to the human R901X mutations. 
The first part of this work includes the generation of R607H and L919X KI mice by site 
specific mutagenesis and homologous recombination. The second part of this study comprises 
the analysis of the disease phenotypic effects of the missense R607H and the nonsense L919X 
mutations in mice. 
3.1. Generation of Ae 1 knock in mice 
The directed mutations of the Ae 1 gene in the mouse were performed by homologous 
recombination in pluripotent embryonic stem cells. Transfection of murine embryonic stem 
cells (ES cells) with a target vector, which contains segments of genomic sequence of the 
target gene results in the recombination of the genomic sequences with homologous regions in 
target gene.  
The desired recombination events were identified as positive ES cell clones. These ES cell 
clones were expanded in vitro and injected in early mouse embryos (blastocysts). As results of 
successful blastocyst injection chimeric mice were born, these mice were partially made of 
cells from the original blastocysts and parts of the injected recombinant ES cells. These 
animals were used as progenitors for generation of KI mouse lines, although germ cell-
forming stem cells are derived from the injected recombinant ES cells. 
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3.1.1. Construction of the targeting vectors 
The pKO scrambler vector was used as a backbone to clone the targeting constructs for the 
R607H and L919X KI mice. The vector includes a multiple cloning site and a diphtheria toxin 
alpha (DTA) cassette at the 3' end as a negative selection marker. Upon homologous 
recombination the DTA cassette does not integrate into the genome. A random integration of 
the construct with the DTA cassette into the genome leads to the subsequent expression of the 
diphtheria toxin resulting in the cell death. The neomycin resistance cassette (neo) was used 
as a positive selection marker to screen the successful recombination events. NotI linearized 
targeting vector was used for ES cell electroporation  
 
Figure 3.1 Schematic representation of the construction of the R607H KI targeting vector. The distance 
among the exons and the introns have no real co-relation with original gene map. (A) Wild type allele showed 
the mouse genomic fragment including exon 14 which carried the desired mutation site. (B) Mouse genomic 
fragment was cloned into pKO vector and an extra HindIII site was introduced to control the successful 
recombination. A change from CGA(R) →CAT ( ) results in R607  mutation. (C) Successful cre-
recombination resulted in the excision of neo-cassette. 
Two independent ʎ-phage clones comprising the genomic regions of interest to target the 
different parts of the Ae1 gene were isolated and were initially cloned into the pBluescript II 
KS
+
 vector. Sequencing of the Ae1 genomic fragments revealed the targeting vectors for both 
KI mice. R607H fragment included exon 2 to exon 18 and the L919X KI construct comprised 
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of exon 14 to exon 20 with a 3' flanking arm of 10 kb. These genomic fragments were 
subsequently cloned into the PKO Scrambler V901 vector carrying the DTA cassette. 
 
Figure 3.2 Schematic representation of the construction of the L919X KI targeting vector. The distance 
among the exons and the introns have no real co-relation with original gene map. (A) Wild type allele indicated 
by the isolated mouse genomic fragment used for the generation of targeting construct including exon 20 carried 
the desired mutation site. (B) Mouse genomic fragment was cloned into the pKO vector with the neo selection 
cassette. An extra EcoRV site was introduced to control the successful recombination. A site directed 
mutagenesis led to a change of CTG (L) →TAG(X) resulted in L919X. (C) Successful cre-recombination 
excised the neo-cassette in knock in allele. 
In case of the R607H KI mouse model a 1.5 kb fragment was subcloned with SpeI and 
Bstz17I to generate a point mutation by site specific mutagenesis. This point mutation led to a 
single amino acid change from arginine (R) to histidine (H). The neo-cassette flanked by loxP 
sites (floxed neo) was inserted as a positive selection marker at the PciI restriction site of the 
EcoRV-XhoI subclone. An extra HindIII site was introduced close to the point mutation in the 
neighbouring intron for selection of the positively recombined clones by southern blot 
analysis with an external 3' probe (figure 3.1). 
 
 
41 
Ae1 mouse genomic fragment carrying the exon 20 was used to create the targeting construct 
for L919X KI mouse model. The nonsense mutation L919X was introduced in a sub clone by 
site directed mutagenesis. The change from leucine (L) to stop codon (X) that led to the 
truncation of last 11 amino acids of the Ae1 protein. An EcoRV-AscI linker was added closed 
to the target exon, at the BspHI restriction site to place the floxed neo cassette. The insertion 
on an extra EcoRV restriction site enabled the successful verification of recombined clones 
via southern blot with a 5' external probe (figure 3.2). 
3.1.2. Detection of homologous recombination  
The targeting vectors for both mouse lines were linearized with NotI and transfected into the 
ES cells by electroporation. ES cells were treated with (neomycin) selection medium and 300- 
400 neomycin resistant ES cell clones were isolated. These clones were expanded and 
passaged into four replica plates. Two replica plates were frozen and the remaining two were 
used for the extraction of genomic DNA. The cell culture was performed by the members of 
the core unit for transgenic animals’ facility of the University hospital Jena. 
 
Figure 3.3 Southern blot strategy used for the detection of homologous recombination in R607H ES cell 
clones. (A) A 20 kb of genomic fragment can be detected in southern screening as a WT allele. (B) In case of 
successful recombination a 4.8 kb genomic fragment can be seen in KI allele due to presence of an extra HindIII 
site via an external 3' probe. Four hundred ES clones were analysed by southern blot and one of the four positive 
ES clones was injected to generate R607H KI mouse line. 
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Successful recombination events in the ES cell clones was analysed by southern blot. Either 
HindIII or EcoRV were used as restriction enzymes for the digestion of the genomic DNA of 
the R607H and L919X clones, respectively. 
The HindIII digestion of the genomic DNA of R607H clones resulted in wild type fragments 
of 20kb and a recombinant fragment of 4.8 kb due to the insertion of an extra HindIII 
restriction site in the targeting vector. These DNA fragments were identified with a 
downstream 3' external probe (Figure 3.3 for schematic representation). 
 
Figure 3.4 Southern blot strategy used for the detection of homologous recombination in L919X ES cell 
clones. (A) A wild type allele can be distinguished as a 9.1 kb of genomic fragment by an external 5' southern 
probe. (B) Accomplishment of the recombination was indicated by a 6.1 kb genomic fragment via a 5' southern 
probe in KI allele. Three hundred ES clones were analysed by southern blot and one of the nine positive ES 
clones was injected to generate R607H KI mouse line. 
In case of L919X ES clones the EcoRV digestion of the genomic DNA showed the 
successfully recombined clones with a wild type band of 9.1 kb and a recombinant band of 
6.1 kb. These DNA fragments were identified with an upstream 5' external probe (Figure 3.4 
shows the details). 
The southern blot results revealed the successful recombination events in both of the KI 
mouse lines. The 
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P labelled probes were used to detect the wild type and recombinant allele 
band. Two successfully recombined clones from each KI line were chosen, expanded and then 
injected into 3.5 days old blastocysts harvested from C57BL/6J mouse line. 
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Injected blastocysts were then transferred into the uterus of C57BL/6J foster mice. Foster 
mice gave birth to male chimeric mice, which were bred with C57BL/6J female mice. The 
successful germ line transfer was analysed by the coat colour and genotyping PCR. The 
presence of the mutations was verified by sequencing in both KI mouse lines. Both the 
R607H and the L919X KI mouse lines were mated with cre-recombinase expressing mice to 
delete the floxed neo cassette. After removal of the neo-cassette the cre-recombinase 
transgene was removed by breeding. For experiments only neo negative mice were used. 
 
Figure 3.5 Southern blot analyses of both KI mouse lines. Homologous recombination in R607H KI mice was 
observed by KI band at 4.8kb and wild type band (control) at 20kb. In the same way L919X mice have shown a 
successful recombination by a 6.1 kb KI band and the 9.1 kb WT band.  
3.1.3. Confirmation of germ line transfer in both KI mice 
As a result of site directed mutagenesis two independent mouse lines (R607H & L919X) were 
obtained. Several methods were used for the confirmation and analysis of germ line transfer 
from chimeric mice. Genotyping PCR was one of the methods used most frequently to keep 
track of the genotype of new born mice after each breeding step.  
At first the successful removal of the neo-cassette was confirmed by a genotyping PCR. Three 
primers were used to detect the presence or absence of the neo-cassette. When the mice were 
obtained without neo-cassette, only one primer set (Forward & Reverse) was used to trace the 
mice genotype for each knock in line independently (Figure 2.1 & 2.2 shows the detailed 
genotyping PCR scheme). 
The germ line transfer was further verified by southern blot analysis. The genomic DNA 
purified from mice tail biopsies was used in this analysis. The 3' and 5' radiolabelled external 
probes were taken to trace the germ line transfer in R607H and L919X KI mice, respectively.  
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The results obtained from genotyping PCR and southern blot analysis could reveal the 
successful recombination and germ line transfer.  
 
Figure 3.6 Genotyping PCR of R607H and L919X KI mice. Mice genomic DNA from tail biopsies were used 
for the genotyping PCR. In R607H mice WT band of 197 bp and KI band at 320 bp can be seen. In L919X mice 
the WT band of 321 bp and the KI band at 444 bp were observed. 
The existence of the desired mutations at specific sites in both KI mouse lines was controlled 
with the sequencing of the mouse genomic DNA. 
 
Figure 3.7 Electropherogram of for both KI mice. Point mutations in KI mice are indicated by *. In R607H 
mice a change from CGA (R) to CAT (H) and in L919X mice CTG (L) to TAG (stop codon) can be seen. 
3.2 Phenotypic characterization of Ae1 KI mice  
The phenotypic analysis of both KI mice was an important part of the study. It was expected 
that both mutants serve as a model for autosomal dominant (AD) type of distal renal tubular 
acidosis (dRTA). Phenotypic analysis showed both KI mice were born at the expected 
Mendelian ratio (100 pups for each KI mouse line), indicating no embryonic lethality. Both of 
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the KI mice were normal at birth, were viable, fertile and could not be distinguished from 
their genetically unmodified siblings. A statistical analysis of the body weight and the body 
size of KI verses WT animals showed no significant differences (data not shown).  
3.3. Blood and urine analysis of (R607H & L919X) mice 
Blood gas parameters and urine pH of wild type and littermates R607H KI, L919X KI was 
examined under steady state conditions. 
Table 3.1 Blood gas values and urine electrolyte composition in R607H KI mice. Urine electrolytes were 
normalized to urine creatinine. The data shown are mean values ±SEM. 
R607H mice    WT (n=6)   KI (n=6) p-value 
Blood 
          
pH 
 
7,31 ± 0,01 
 
7,28 ± 0,02 
 
0,24 
pCO2 (mmHg)  
48,28 ± 0,77 
 
51,66 ± 1,58 
 
0,06 
HCO3
- 
(mM)   24,14 ± 0,75   23,65 ± 0,97   0,69 
    WT (n=6)   KI (n=6) p-value 
Urine 
          
pH 
 
6,83 ± 0,07 
 
7,67 ± 0,07 
 
0,00001 
Creatinine(mM) 
 
3,58 ± 0,25 
 
4,25 ± 0,15 
 
0,04 
[Na
+
/Creatinine](mM) 
 
34,35 ± 2,51 
 
41,67 ± 1,78 
 
0,03 
[K
+
/Creatinine] (mM) 
 
102,2 ± 11,3 
 
120,1 ± 11,9 
 
0,29 
[Cl
-
/Creatinine] (mM) 
 
46,68 ± 5,15 
 
48,51 ± 3,35 
 
0,77 
[NH4
+
/Creatinine] (mM) 
 
4,6 ± 0,39 
 
1,96 ± 0,28 
 
0,0003 
 
Table 3.2 Blood gas values and urine electrolyte composition in L919X KI mice. Urine electrolytes were 
normalized to urine creatinine. The data shown are mean values ±SEM. 
L919X mice   WT (n=8)   KI (n=8) p-value 
Blood 
          
pH 
 
7,33 ± 0,01 
 
7,317 ± 0,01 
 
0,34 
pCO2 (mmHg)  
49,87 ± 1,27 
 
51,13 ± 1,73 
 
0,57 
HCO3
- 
(mM)   26,01 ± 0,65   25,53 ± 0,99   0,69 
    WT (n=6)   KI (n=6) p-value 
Urine 
          
pH 
 
6,77 ± 0,04 
 
7,322 ± 0,07 
 
0,0001 
Creatinine(mM) 
 
4,16 ± 0,15 
 
3,97 ± 0,16 
 
0,41 
[Na
+
/Creatinine](mM) 
 
33,81 ± 0,9 
 
36,9 ± 1,19 
 
0,06 
[K
+
/Creatinine] (mM) 
 
91,71 ± 3,89 
 
103,5 ± 2,9 
 
0,03 
[Cl
-
/Creatinine] (mM) 
 
45,67 ± 3,09 
 
51,31 ± 2,74 
 
0,2 
[NH4
+
/Creatinine] (mM) 
 
4,32 ± 0,59 
 
3,02 ± 0,55 
 
0,13 
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3.3.1. Urine analysis of KI mice 
WT and KI mice 8-12 weeks of age of both genders were housed in metabolic cages to collect 
urine. Urine was collected under oil for 24h at the same time on consecutive days. The 
concentrations of substances in the urine were normalized to urine creatinine (Table 3.1 & 
3.2). All parameters of the urine of both KI mice were compared with their respective wild 
type littermates. On day 7 of the experiment mice were challenged with an acid load in the 
form of 0.28M NH4Cl for 24h, which is a standard test to study an acid secretion defect of the 
kidney. Differences in urine pH were observed in both KI mouse lines indicating a renal acid 
secretion defect (Figure 3.8). Significance levels were analysed by a 2-Way ANOVA and post 
hoc test. 
 
Figure 3.8 Urine pH analysis of R607H and L919X KI mice. Urine was collected after every 24h interval, on 
day 7 mice were challenged with the acid load of 0.28 M NH4Cl a decrease in the pH is observed. Both KI mice 
have shown a significant difference. 2-Way ANOVA and post hoc test was performed to test the significance of 
repeated measurements. 
 
Figure 3.9 Blood gas analysis of R607H and L919X KI mice with respective littermates. Both KI mice did 
not show any significant difference in blood pH values as well as the pCO2 and the HCO3
−
 concentrations. 
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3.3.2. Blood gas analysis of KI mice 
Blood samples of both KI mouse lines with their respective littermates of both genders were 
analysed. Blood pH and HCO3
–
 concentration in WT and KI were indistinguishable therefore; 
no significant difference in blood pH, pCO2 and HCO3
−
 values was observed (Figure 3.9). 
3.4. Ae1 expression studies in KI mice by immunohistochemistry 
The kidney specific shorter isoform of the Ae1 is strongly expressed in highly specialized and 
polarized, acid secreting cells (α-IC) of the distal tubule in kidney. Ae1 is a membrane protein 
and its localization is confirmed to the basolateral membranes of the α-IC cells. Here, Ae1 
localization and expression was analysed by immunofluorescence staining of 8-10 weeks old 
R607H and L919X KI mice.  
3.4.1. Immunohistochemical analysis of R607H mice 
To evaluate the expression of Ae1 in mouse kidney, immunohistochemistry was performed by 
using 7µm thick frozen sections. The antibodies directed against Ae1 and pendrin 
demonstrated basolateral staining of the Ae1 in α-IC cells of the cortical and medullary 
collecting ducts (CCD, MCD). The distribution of the pendrin staining was observed 
 redominantly in a ical sides of β- IC cells along the CCD. Immunohistochemistry revealed 
abundant fluorescence labelling of Ae1 and pendrin in WT mice compared to a reduced level 
of the Ae1 expression in the cortex of the R607H KI mice kidney.  
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Figure 3.10 Expression of Ae1 in α-intercalated cells and Pendrin in β-intercalated cells of R607H mice. 
Immunofluorescence staining of Ae1 (Alexa Fluor 488-mediated green staining) and Pendrin (Alexa Fluor 555-
mediated red staining) was performed on 0.7µm thick kidney cryosections. Immunolocalization of Ae1 to the 
basolateral side of the α-intercalated cells and the Pendrin to the a ical sides of the β-intercalated cells were 
observed. DAPI was used to stain cell nuclei. (Scale bar 50µm) 
There was no difference recognized in Ae1 expression in the medulla in R607H KI mice 
compared to WT littermates (figure 3.10).  Homozygous KI (both alleles with R607H 
mutation) mice have almost lost the Ae1 staining in the cortex and a residual protein 
expression can be seen in the medulla. 
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The number and subtypes of IC cells was quantified in the CCD and MCD by 
immunofluorescence staining of Ae1, vH
+
-ATPase and Pendrin. IC cells were defined as 
those stained positive for the B1 subunit of the vH
+
-ATPase. The α-IC cells were defined as 
those that did not ex ress  endrin, whereas β-IC cells had pendrin staining.  
These results revealed a significant decrease in number of Ae1 stained cells in the cortex as 
well as in the medulla of R607H KI versus WT mice (Figure 3.14 A). The number of Pendrin 
positive cells in the cortex remains unchanged in R607H KI mice compared to WT 
littermates. The immunofluorescence quantification also showed that the expression of 
pendrin was limited to the cortical collecting ducts and connecting tubules and the staining 
was absent from the medullary collecting duct.  
 
Figure 3.11 Analysis of the number of α and β-intercalated cells in R607H mice.  (A) The number of α and 
β-intercalated cells quantified in cortex and medulla. Ae1 and Pendrin were used as the markers for α and β-IC 
cells res ectively. The number of α-IC cells in cortex and medulla of KI mice was significantly reduced as 
compared to the WT mice. (B) The total number of IC cells in the cortex com ared with only β-IC cells in the 
cortex. There was no significant difference found in any of the group. 
 
The quantification of V-ATPase stained cells in the cortex was performed to analyse the 
difference in number of α-IC cells in the cortex. The cells stained with the vH+-ATPase anti 
body indicated no difference in the number of α-IC cells in the cortex (Figure 3.14 B). The 
quantification results could signify a reduction of Ae1 stained cells in R607H KI mice instead 
of change in the number of α-IC cells in the cortex.  
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3.4.2. Immunohistochemical analysis of L919X mice  
The expression of Ae1 in L919X KI mice was analysed compared to the WT littermates by 
immunofluorescence staining of frozen kidney sections. In two independent experiments, the 
first set of studies was performed with antibodies directed against Ae1 and vH
+
-ATPase 
(figure 3.12). The second set of studies accomplished with the antibodies targeted to Ae1 and 
pendrin in L919X KI and WT kidney sections (figure 3.13). 
The immunofluorescence labelling demonstrated the basolateral staining of Ae1 in α-IC cells 
of the CCD and MCD of kidney. The distribution of the vH
+
-ATPase staining was observed 
predominantly in apical and sub-a ical sides of both α- & β- IC cells along the CCD and 
MCD. Immunohistochemistry revealed abundant fluorescence labelling of Ae1 and vH
+
-
ATPase in WT mice. A reduced level of the Ae1 expression was observed in the cortex of the 
KI mice kidney. There was no difference recognized in the expression of Ae1 in the medulla 
in KI mice compared to WT littermates. 
A further Immunohistochemical analysis of L919X KI mice kidney by double 
immunofluorescence staining of Pendrin and Ae1 was performed. The WT littermates were 
compared with the heterozygous KI and homozygous KI mice. The kidney cortex exhibited a 
decrease in the expression of Ae1 in heterozygous and homozygous KI mice. In homozygous 
KI mice the Ae1 expression is completely lost in the cortex but the Ae1 staining in the 
medulla indicated the presence of some residual Ae1 protein. There was no change observed 
in the subcellular localization of the heterozygous and homozygous L919X KI mice. 
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Figure 3.12 Localization of Ae1 in α-IC of L919X mice. Immunostaining of Ae1 (Alexa Fluor 488 green) and 
V-ATPase (Alexa Fluor 555 red) was performed on 0.7µm thick kidney cryosections. Ae1 is localized at the 
basolateral side of α-intercalated cells and the vH+-ATPase is located at the apical side of the same cell type. 
DAPI was used to stain cell nuclei. (Scale bar 50µm) 
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Figure 3.13 Expression of Ae1 in α-intercalated cells and Pendrin in β-intercalated cells of L919X mice. 
Immunostaining of Ae1 (Alexa Fluor 488 green) and Pendrin (Alexa Fluor 555 red) were performed on 0.7µm 
thick kidney cryosections. Immunolocalization of Ae1 at the basolateral side of α-intercalated cells and the 
Pendrin to the a ical sides of the β-intercalated cells were observed. DAPI was used to stain cell nuclei. (Scale 
bar 150µm) 
 
Foe each KI and WT littermates six sections were used for the quantification. The kidney 
sections were either co-stained with Ae1 and Pendrin or vH
+
-ATPase and Pendrin. The 
number of Ae1 stained cells in the cortex was significantly decreased in L919X KI mice 
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compared to the WT littermates. Interestingly, no significant difference was observed in Ae1 
positive cells in MCD in L919X KI mice compared to WT animals. 
The number of pendrin positive cells in the cortex remains unchanged in KI mice versus WT 
littermates. The immunofluorescence quantification also revealed that the expression of 
pendrin was limited to the cortical distal segments of the nephron and the staining was absent 
from the MCD. There was no difference observed in the number of vH
+
-ATPase stained cells 
in the CCD of L919X KI mice in comparison with WT littermates (Figure 3.14). 
 
 
Figure 3.14 Analysis of the number of α and β-IC cells in L919X mice. (A) The number of α and β-IC 
quantified in cortex and medulla. Ae1 and pendrin were used as the markers for α and β-IC cells respectively. 
The number of α-IC cells in the cortex of KI mice was significantly reduced as compared to the WT mice. (B) 
The total number of IC cells in the cortex com ared with only β-IC cells in the cortex. There was no significant 
difference found in any of the group. 
 
3.5. Analysis of protein expression by immunoblot 
In order to verify the decrease in the Ae1 protein level by a more quantitative approach 
Western blot analysis was performed in L919X KI mice in comparison with WT mice. Two 
independent animals per genotype were used. The kidneys were separated into cortex and 
medulla and the membrane proteins were prepared. Proteins were separated on SDS-PAGE 
and subsequent blotting led to the detection of Ae1 by specific antibody.  
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Results shown in figure 3.15 revealed that there was a decrease in the expression level of Ae1 
protein in the cortex as well as in the medulla of L919X KI mice. The western blot results 
were consistence with the immunohistochemical analysis. β-actin was used as loading control.  
 
Figure 3.15 Immunoblot analysis of Ae1 protein in L919X mice kidney. The Ae1 specific protein band can 
be seen at a  rox.100 kDa. β-actin was used as loading control. 
 
3.6. Real time Q-PCR analysis of transcript level in both KI mice 
Transcript levels for both KI mice (R607H & L919X) were analysed by Real time 
quantitative PCR to detect any change in the transcript abundance. The kidneys were 
separated into cortex and medulla to isolate the mRNA from both KI mice. 50ng of cDNA 
was used for each PCR reaction. Analysis of the ct values indicated a 2 fold decrease in the 
mRNA level of R607H KI mice cortex versus WT mice but no difference was observed for 
the medulla. There was no significant difference found in the case of L919X KI verses WT 
mice. A decrease of Ae1 transcript was observed in R607H KI mice compared to WT mice 
but only 2 animals per genotype were taken. β-actin was used to normalise the values. 
 
Figure 3.16 RT-PCR analyses of mRNA levels in both KI mice. (A) R607H mice have shown a 2-fold 
decrease in mRNA level in cortex but no difference can be observed in medulla. (B) L919X mice have shown no 
significant difference in transcript levels. β-actin was used to normalise the values. 
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4. Discussion 
The anion exchanger 1 is a member of the SLC4 family (Romero, Fulton et al. 2004) which 
mediates Cl
−
/HCO3
−
 exchange in red blood cells as well as in the α-intercalated cells (α-IC) of 
collecting ducts in kidney (Rothstein and Ramjeesingh 1982; Drenckhahn, Schluter et al. 
1985). Mutations in AE1 are the main cause of hereditary distal renal tubular acidosis (dRTA) 
in the kidney and structural disorders of red blood cells in humans (Casey and Reithmeier 
1998; Bruce and Tanner 1999; Tanner 2002). These mutations are primarily deletions or 
amino acid substitutions of the amino acids, that do not affect the anion exchange function of 
the protein (Yenchitsomanus, Kittanakom et al. 2005). 
 
R589H and R901X are two frequent human mutations of AE1 in autosomal dominant dRTA 
(Bruce, Cope et al. 1997; Jarolim, Shayakul et al. 1998; Toye, Bruce et al. 2002).  
To study the detailed pathophysiology of these mutations in an in vivo system, we have 
generated two knock-in mouse models to mimic the human dRTA phenotype. Cell culture 
studies have suggested that these mutations cause mistrafficking of the protein. Absence of 
any immortal cell line originated from intercalated cells was an obstacle to correlate the 
human phenotype to cell culture systems (Shayakul and Alper 2004; Toye 2005; Cordat 
2006). An important aim of the study was to provide an in vivo system to address the 
shortcomings of the cell culture system. 
 
4.1. Generation of knock-in mice 
Gene targeting via homologous recombination was used to generate both KI mouse models. 
To generate the mouse mutants, the human (AE1) and mouse (Ae1) protein sequences were 
aligned to identify the corresponding amino acids in the mouse. Both KI mice generated and 
analysed during this study carry the respective mutations. Successful generation of the KI 
mice was confirmed by southern blot and sequencing of the respective mutated sites.  
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4.2. R607H and L919X mice exhibit distal renal tubular acidosis 
Both KI mice were characterized for the distal renal tubular acidosis by metabolic cage 
experiments, (Stehberger, Shmukler et al. 2007) to identify any change in the urine pH as seen 
in the patients carrying the same mutations (Yenchitsomanus, Kittanakom et al. 2005). 
Analysis of the urine which was collected over a 24 hour period revealed that there was a 
significant increase in the urine pH in KI mice as compared to WT littermates. This indicates 
the insufficiency of the KI mouse kidneys to acidify the urine that leads to dRTA in these 
mice.  
A classical acid load test with NH4Cl (Wrong and Davies 1959; Chambrey, Goossens et al. 
2005; Stehberger, Shmukler et al. 2007) was performed over a period of 24 hours. Urine pH 
in R607H WT mice dropped to pH 5.5 whereas KI mice failed to acidify their urine pH below 
6.5. This is consistent with a defect in normal urine acidification. Human patients 
heterozygous for R589H (Karet, Gainza et al. 1998) failed to acidify the urine pH below 5.7 
after a standard acid load test. The significant difference between the urine pH in KI versus 
WT mice was observed over a period of one week. Surprisingly the impaired urine 
acidification did not result in systematic acidosis as seen in the blood gas analysis of the KI 
mice. So, it is likely that there is still residual acid secretion mechanism to compensate the 
effect of the acid secretion defect in these mice. There are several proteins (AE2, AE3, AE4 
and NBCn1) expressed in the renal distal tubule and their role in renal acid base balance is 
still unknown (Wagner, Devuyst et al. 2009) therefore, both of these KI mice displaying 
dRTA can serve as an interesting model to uncover the role of other proteins in distal tubule 
acid secretion. 
The second KI model carried the L919X mutation which correspond to the human R901X 
mutation was also established (Toye, Bruce et al. 2002). L919X KI mice were also analysed 
for any change in the urine pH and again a significant difference was found in mutated mice 
under steady state conditions. Human patients with this truncating mutation (R901X) were 
also unable to acidify urine after an acid load test (Toye, Bruce et al. 2002). L901X KI mice 
treated with NH4Cl failed to acidify the urine, a feature of classical dRTA.  
Both KI mice did not show any abnormality in the erythrocyte shape or structure, indicating 
that these mutations do not interfere with red blood cell function and only affect the distal 
tubules in the kidney. In human patients carrying either AE1 R589H missense mutation or the 
R901X truncating mutation, no clinical red blood cells abnormalities have been observed 
(Jarolim, Shayakul et al. 1998; Rodriguez-Soriano 2000; Toye, Bruce et al. 2002). 
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The analysis of blood pH and HCO3
−
 concentration in both KI mice did not show differences 
compared to the WT littermates. This can be observed commonly in an autosomal dominant 
form of dRTA. It is often observed that the blood HCO3
−
 concentration stays normal, and the 
defect in renal acid excretion can only be demonstrated by an acid load (Laing, Toye et al. 
2005). The human patients carrying the corresponding  heterozygous dominant mutation in 
the AE1 gene, diagnosed with hereditary autosomal dominant (AD) dRTA (Karet, Gainza et 
al. 1998; Toye, Bruce et al. 2002) have shown no difference in blood pH and HCO3
−
 
concentrations compared to the healthy patients.  
 
Mutations in the B1 and a4 subunits of the vacuolar H
+
-ATPase are also responsible for 
dRTA in humans (Karet, Finberg et al. 1999; Smith, Skaug et al. 2000; Stover, Borthwick et 
al. 2002). Both of these subunits are expressed in all types of intercalated cells (Finberg, 
Wagner et al. 2003; Stehberger 2003; Miller, Zhang et al. 2005). Interestingly, a mouse model 
deficient for the B1 subunit of the vH
+
-ATPase does not show obvious signs of metabolic 
acidosis (Finberg, Wagner et al. 2005) as well, although patients with a B1 defect are severely 
affected. This may be explained by differences in acid secretion in mouse and man. 
In contrast, a mouse model lacking Ae1 (slc4a1
-/-
) both in red blood cells and the kidney α-
intercalated cells had a high postnatal lethality, possibly as a result of anaemia and metabolic 
acidosis (Akel, Wagner et al. 2007; Stehberger, Shmukler et al. 2007). Mice surviving into 
adulthood showed retarded growth, severe hyperchloremic metabolic acidosis, and an 
inappropriately alkaline urine pH with reduced net acid excretion (Stehberger, Shmukler et al. 
2007). Similarly, Ae1-deficient mice show renal calcium phosphate calcifications, 
predominantly in the medulla similar to dRTA patients, and have higher urinary phosphate 
and calcium excretion with reduced citrate levels. Ae1 deficient mice thus show a wide 
spectrum of phenotypic alterations reflecting the symptoms of inborn dRTA (Wagner 2007). 
It is also known that patients with autosomal dominant dRTA differ from those with 
autosomal recessive dRTA in clinical presentation and disease severity. Autosomal recessive 
dRTA is frequently associated with a family history of consanguinity, is manifested early in 
life and is usually associated with a more severe phenotype than autosomal dominant dRTA 
and also linked with hereditary deafness (Batlle, Ghanekar et al. 2001).  
Secondary effects of dRTA in patients such as growth retardation, osteomalacia, 
hypercalciuria, hypocitraturia and nephrocalcinosis are common (Alper 2010). These effects 
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have been described either in recessive or dominant conditions (Fry and Karet 2007). Patients 
with recessive mutations are more sensitive to the secondary effects of dRTA such as growth 
retardation and nephrocalcinosis compared to the patients with the dominant mutations.  
Up to the age of 4 months no secondary effects related to the dRTA phenotype was observed 
in R607H and L919X mice. It would be interesting to observe secondary effects of dRTA in 
both KI mice at older age. It is common to identify the dRTA phenotype in patients with 
dominant AE1 mutations in adult age (Jarolim, Shayakul et al. 1998; Karet, Gainza et al. 
1998; Toye, Bruce et al. 2002).  
A significant decrease in NH4
+
 secretion into the urine is observed in R607H KI mice, this is 
also sometimes observed in patients with dRTA as they have low ammonia secretion rates due 
to the failure to trap ammonia in the tubular lumen of the collecting duct because of the 
inability to lower the luminal pH (Dubose 2008). 
4.3. Immunohistochemical analysis revealed a decreased Ae1 expression in kidney α-
intercalated cells 
Immunohistochemistry was performed to analyse the localization and expression of Ae1 in 
the kidney of R607H and L919X KI mice.  
Kidneys of R607H KI mice were first analysed for the localization and expression of Ae1 to 
observe any change in expression and/or localization of Ae1. Ae1 is normally localized to the 
basolateral sides of α-intercalated (α-IC) cells in collecting ducts and the H+-ATPase is 
present on the apical side of the same cells. The H
+
-ATPase also expressed at the apical 
and/or basolateral side of β-intercalated (β-IC) cells (Kopito, Andersson et al. 1987; Alper, 
Natale et al. 1989; Sahr, Taylor et al. 1994; Kim, Kim et al. 1999).  
Our experiments demonstrate a decrease in the expression of Ae1 in α-IC cells of kidney 
tubules in KI mice as compared to the WT littermates, but this effect was more pronounced in 
cortical collecting ducts (CCD) as compared to medullary collecting ducts (MCD). Kidney 
biopsy samples from one human patient carrying the heterozygous R589H mutation have also 
shown a deficiency or total loss of AE1 expression (Shayakul 2004; Shayakul and Alper 
2004) confirming our observations. These observations suggest a reduction of Ae1 expression 
in kidney tubules possibly due to an impairment of the mutant protein trafficking to the cell 
surface. The possible explanation for the reduced cell surface expression of mutated forms of 
Ae1 due to the intracellular retention and degradation of the protein while no significant 
changes in the transcript levels have been monitored in both KI mice models. 
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Extensive in vitro cells culture studies tried to address the cellular consequences of the AD 
dRTA mutation in AE1. Coexpression studies of kAE1 (Kidney AE1) R589H in non-
polarized human embryonic kidney 293 cells (HEK 293) as well as in Madin Darby canine 
kidney cells (MDCK) both in non-polarized and polarized cells indicate a reduction in the cell 
surface expression of AE1. It is thought that the heterodimer formation leads to a dominant 
negative effect (Quilty, Li et al. 2002; Toye, Banting et al. 2004; Cordat, Kittanakom et al. 
2006).  Other missense mutations at amino acid position 589 the R589H, R589C and R589S 
also prevented the trafficking of mutated protein to the cell surface, indicating that this 
conserved arginine residue is important for proper trafficking (Quilty, Li et al. 2002; Wrong, 
Bruce et al. 2002). The frequent involvement of AE1 R589 in different dominant mutations 
suggests that codon 589 is a “mutational hots ot” of AE1 and may imply that, this residue is 
particularly important in the normal acidification process (Rodriguez-Soriano 2000; Pereira, 
Miranda et al. 2009). Arginine at 589 position of human AE1 protein is present at the 
intracellular border of the sixth transmembrane domain next to the Lysine at 590. These basic 
amino acid residues are conserved in all known vertebrate AE1 orthologs and may form part 
of the site of intracellular anion binding (Karet, Gainza et al. 1998).  
 
We next examined whether the absence of Ae1 staining can be ex lained by a reduction of α-
IC cells. A semi quantification was performed for Ae1 and pendrin stained α- and β-IC cells 
in the cortex and the medulla (Gao, Eladari et al. 2010). The counting of IC cells in kidney 
cortex and medulla allowed us to exclude a change in the number of IC cells. A significant 
reduced number of Ae1 positively stained cells in cortex of KI mice versus WT littermates 
was observed. There was no change found in the expression pattern of  endrin in β-IC cells. 
Pendrin stained cells were totally absent in the medulla where β-IC cells are generally not 
detected (Schuster 1990). The significant decrease in the Ae1 expression was also observed in 
the medulla of KI mice com ared to WT. The analysis of total number of α- and β- IC cells in 
cortex was quantified by H
+
-ATPase staining and no difference was observed.  
 
These findings revealed that the R607H mutation leads to a decrease in the cell surface 
expression of Ae1 in comparison to WT mice. Here we showed that the R607H mutation 
results in less cell surface expression possibly due to intracellular retention of the protein in 
endoplasmic reticulum and subsequent degradation. 
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L919X KI mouse was a model for patients with the autosomal dominant truncating mutation 
R901X. It was analysed for the expression and localization of Ae1  rotein in Kidney α-IC 
cells. Mice kidneys were stained with Ae1, pendrin and H
+
-ATPase antibodies and the 
immunohistochemical analysis revealed the reduction of Ae1 expression in KI mice as 
compared to WT littermates.  
 
Early expression studies in non-polarized MDCK cell lines stably transfected with the human 
R901X truncating mutation indicated an intracellular retention of the transfected protein 
(Toye, Bruce et al. 2002). In vitro HEK-293 cells transfection with the R901X truncating 
mutation and cell-surface biotinylation experiments suggested an intracellular retention of the 
mutant protein (Quilty, Cordat et al. 2002). A dominant negative effect resulted in the 
trafficking defect of wild type proteins due to the R901X mutants when co-expressed with 
WT cDNA (Quilty, Cordat et al. 2002).   
 
A series of C-terminal truncations were studied to resolve the role of the C-terminal domain 
for Ae1 expression, which led to the conclusion that these mutations impair the protein 
trafficking to the cell membrane (Cordat, Li et al. 2003).  Another important study in 
polarized kidney-derived MDCK cells suggested loss of polarized trafficking of Ae1 as the 
primary cause of dysfunction of α-IC cells dRTA associated with Ae1 truncating mutation 
(Devonald, Smith et al. 2003).  
 
This abnormal distribution of R901X mutant was mimicked in epitope tagged kAE1-Y904A, 
suggested an im ortant role for the “YXXF” sorting motif (904YDEV907) in the selectively 
basolateral accumulation of kAE1 and pointed out the role of C-terminal tail carrying the 
basolateral targeting signal (Devonald, Smith et al. 2003). The C-terminal mutation (R901X) 
contains a tyrosine motif and a type II PDZ interaction domain and this tyrosine residue 
(Tyr904), but not the PDZ domain, is critical for basolateral localization of AE1  rotein in α-
IC cells (Toye 2005). 
 
These studies revealed the role of the C-terminal tail of Ae1 in protein trafficking to the 
basolateral membrane in polarized cells and the authors used polarized MDCK and rat IMCD 
cell lines in the absence of a better model for α-intercalated cells. Polarization of kidney cells 
is obviously associated with changes in the endogenous trafficking pathways that result in the 
generation of discrete apical and basolateral membrane domains (Toye, Bruce et al. 2002). 
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The R901X truncated protein still retains the carbonic anhydrase II (CA II) binding motif and 
shows no defect in CA II binding (Quilty, Cordat et al. 2002). The immunofluorescence 
staining of the L919X KI mice exhibits a reduction of Ae1 ex ression in the α-IC cells of the 
CCD in kidney tubules. Our observation did not show any mistargeting of the mutant protein 
to the a ical side of the α-IC cells instead of the basolateral side.  
The semi quantitative analysis of the Ae1 expression in L919X KI Kidney versus WT was 
performed by counting IC cells independently in the cortex and medulla. The counting of the 
Ae1 and pendrin stained IC cells helped us to confirm a decrease in the expression of Ae1 in 
the α-IC cells rather than a difference in the number of α- & β- IC cells.  
 
These studies revealed a significant reduction in the expression levels of Ae1 in the CCD in 
KI mice versus WT littermates but the expression pattern of pendrin in β-IC cells remained 
same. The expression of Ae1 in MCD also remained same in KI compared to WT mice. The 
H
+
-ATPase staining revealed no alteration in the number of IC cells in the cortex. This 
analysis helped to exclude the  ossibility of reduction in α-IC cell number. Therefore, it is 
proposed that both mutant mice have an intracellular retention of the protein and this is 
perhaps the cause of dRTA phenotype. 
 
Angiotensin II and aldosterone stimulates the H
+
-ATPase activity in α-intercalated cells and 
the upregulation of the renin–angiotensin–aldosterone system during metabolic acidosis has 
been well documented. It is thought angiotensin and aldosterone participates in the 
compensatory increase in renal acid excretion (Rothenberger, Velic et al. 2007; Winter, 
Kampik et al. 2011). Consequently, it would be interesting to investigate the levels of 
Angiotensin II and aldosterone in these mutant mice. 
 
Breeding of the heterozygous KI mice results the homozygous KI mice for both independent 
mouse lines. These mice were viable and showed no morphological differences compared to 
the heterozygous littermates. Immunoflorescence staining of Ae1 was analysed in both 
homozygous KI mice. R607H homozygous KI mice showed almost loss of Ae1 protein in 
CCD however residual protein expression can be observed in MCD. The same effect was 
observed in L919X homozygous KI mouse line. 
 
The reduction of Ae1 staining was subsequently studied by western blot analysis. These 
results showed a reduction of Ae1 expression in L919X KI mice as compared to the WT 
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littermates. These observations were consistent with the Immunohistochemical analysis of KI 
mice kidney. This dramatic decrease in the Ae1 protein concentration can be due to the 
dominant negative effect resulted in the intracellular degradation of the protein. The dRTA 
phenotype observed in these mice is possibly due to reduced expression of the functional 
protein at cell surface. 
 
Reverse Transcriptase quantitative PCR (RTq-PCR) analysis of both KI mice was performed 
with the RNA isolated from the dissected cortex and medulla of KI and WT mice kidney 
(Bonnici and Wagner 2004). Three and two mice were used respectively for L919X and 
R607H in each genotype group. Analysis of the results was done according to the Delta Delta 
Ct Method (Livak and Schmittgen 2001; Schmittgen and Livak 2008).  
By analysing the RTq-PCR results no significant change at the transcript levels in L919X KI 
mice with respect to the WT littermates has been observed. Immunohistochemical analysis 
and the immunoblotting results demonstrate a decrease in protein expression possibly due to 
the protein degradation. Therefore, it was expected that there is no observable change present 
in the transcript level of KI mice versus WT littermates.  
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5. Concluding remarks 
The anion exchanger 1 (AE1) gene encodes two isoforms expressed in erythrocytes (eAE1) 
and in acid secreting intercalated (α-IC) cells of the kidney (kAE1). AE1 contributes to 
urinary acidification by providing the important exit route for HCO3
−
 across the basolateral 
membrane (Batlle, Ghanekar et al. 2001). Mutations in AE1 are the major cause of hereditary 
autosomal dominant distal renal tubular acidosis in human.  
Both KI mouse models generated during this study exhibit a failure to acidify the urine due to 
a defect in H
+
-secretion. A reduced expression of Ae1 in KI mice kidneys was observed 
compared to the WT littermate. This may suggest an intracellular retention of mutant protein 
due to dominant negative effect. Further investigation is required to elucidate whether 
intracellular retention of the protein underlies dRTA. The effect of the long term exposure to 
acid and its effect on kidney function also have to be addressed in the future. 
Homozygous KI mice did not show any gross morphological or physiological defect up to the 
age of 8 week. It can only be explained by some unknown H
+
 secretory pathway and a 
compensatory HCO3
–
 reclamation in the blood. Any change in the expression levels or other 
important proteins such as pendrin or H
+
-ATPase in the distal collecting tubules of the kidney 
also needs to be analysed. Candidates for this regulation are AE2, AE3, AE4 and NBCn1. 
Further studies have to address whether one or more of these candidates are involved in 
compensatory pathways. These mice will also allow the investigation of the underlying 
mechanisms of secondary manifestations of the disease such as nephrocalcinosis that was 
limiting in cell culture system. 
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